<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54612</article-id><article-id pub-id-type="doi">10.7554/eLife.54612</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Regulation of nerve growth and patterning by cell surface protein disulphide isomerase</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-169573"><name><surname>Cook</surname><given-names>Geoffrey MW</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169589"><name><surname>Sousa</surname><given-names>Catia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177875"><name><surname>Schaeffer</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169591"><name><surname>Wiles</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169592"><name><surname>Jareonsettasin</surname><given-names>Prem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169593"><name><surname>Kalyanasundaram</surname><given-names>Asanish</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169594"><name><surname>Walder</surname><given-names>Eleanor</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169595"><name><surname>Casper</surname><given-names>Catharina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169596"><name><surname>Patel</surname><given-names>Serena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169597"><name><surname>Chua</surname><given-names>Pei Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169598"><name><surname>Riboni-Verri</surname><given-names>Gioia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169599"><name><surname>Raza</surname><given-names>Mansoor</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169600"><name><surname>Swaddiwudhipong</surname><given-names>Nol</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169601"><name><surname>Hui</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169602"><name><surname>Abdullah</surname><given-names>Ameer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-169603"><name><surname>Wajed</surname><given-names>Saj</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-43525"><name><surname>Keynes</surname><given-names>Roger J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1557-7684</contrib-id><email>rjk10@cam.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Physiology, Development and Neuroscience, University of Cambridge</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>Grenoble Institute des Neurosciences</institution><addr-line><named-content content-type="city">La Tronche</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Independent researcher</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution>Exeter College</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution>School of Clinical Medicine, Cambridge University Hospitals</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution>Winter, Brandl, Fürniss, Hübner, Röss, Kaiser &amp; Polte, Partnerschaft mbB, Patent und Rechtsanwaltskanzlei</institution><addr-line><named-content content-type="city">München</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution>School of Medicine and Health Sciences, Monash University</institution><addr-line><named-content content-type="city">Bandar Sunway</named-content></addr-line><country>Malaysia</country></aff><aff id="aff8"><label>8</label><institution>School of Medicine, Medical Science and Nutrition, University of Aberdeen</institution><addr-line><named-content content-type="city">Aberdeen</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff9"><label>9</label><institution>Cambridge Innovation Capital</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff10"><label>10</label><institution>University of Exeter Medical School</institution><addr-line><named-content content-type="city">Exeter</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mason</surname><given-names>Carol A</given-names></name><role>Reviewing Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>28</day><month>05</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e54612</elocation-id><history><date date-type="received" iso-8601-date="2019-12-19"><day>19</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-05-23"><day>23</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Cook et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Cook et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54612-v3.pdf"/><abstract><p>Contact repulsion of growing axons is an essential mechanism for spinal nerve patterning. In birds and mammals the embryonic somites generate a linear series of impenetrable barriers, forcing axon growth cones to traverse one half of each somite as they extend towards their body targets. This study shows that protein disulphide isomerase provides a key component of these barriers, mediating contact repulsion at the cell surface in chick half-somites. Repulsion is reduced both in vivo and in vitro by a range of methods that inhibit enzyme activity. The activity is critical in initiating a nitric oxide/S-nitrosylation-dependent signal transduction pathway that regulates the growth cone cytoskeleton. Rat forebrain grey matter extracts contain a similar activity, and the enzyme is expressed at the surface of cultured human astrocytic cells and rat cortical astrocytes. We suggest this system is co-opted in the brain to counteract and regulate aberrant nerve terminal growth.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>spinal nerve</kwd><kwd>repeat patterning</kwd><kwd>somite</kwd><kwd>axon guidance</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Chicken</kwd><kwd>Human</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cook</surname><given-names>Geoffrey MW</given-names></name><name><surname>Keynes</surname><given-names>Roger J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cook</surname><given-names>Geoffrey MW</given-names></name><name><surname>Keynes</surname><given-names>Roger J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007922</institution-id><institution>Spinal Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Schaeffer</surname><given-names>Julia</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000727</institution-id><institution>Trinity College, University of Cambridge</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Keynes</surname><given-names>Roger J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000735</institution-id><institution>University of Cambridge</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cook</surname><given-names>Geoffrey MW</given-names></name><name><surname>Sousa</surname><given-names>Catia</given-names></name><name><surname>Schaeffer</surname><given-names>Julia</given-names></name><name><surname>Wiles</surname><given-names>Katherine</given-names></name><name><surname>Jareonsettasin</surname><given-names>Prem</given-names></name><name><surname>Kalyanasundaram</surname><given-names>Asanish</given-names></name><name><surname>Walder</surname><given-names>Eleanor</given-names></name><name><surname>Casper</surname><given-names>Catharina</given-names></name><name><surname>Patel</surname><given-names>Serena</given-names></name><name><surname>Chua</surname><given-names>Pei Wei</given-names></name><name><surname>Riboni-Verri</surname><given-names>Gioia</given-names></name><name><surname>Raza</surname><given-names>Mansoor</given-names></name><name><surname>Swaddiwudhipong</surname><given-names>Nol</given-names></name><name><surname>Hui</surname><given-names>Andrew</given-names></name><name><surname>Abdullah</surname><given-names>Ameer</given-names></name><name><surname>Wajed</surname><given-names>Saj</given-names></name><name><surname>Keynes</surname><given-names>Roger J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000833</institution-id><institution>Rosetrees Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Cook</surname><given-names>Geoffrey MW</given-names></name><name><surname>Schaeffer</surname><given-names>Julia</given-names></name><name><surname>Keynes</surname><given-names>Roger J</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>The Anatomical Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Walder</surname><given-names>Eleanor</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000042</institution-id><institution>Amgen Foundation</institution></institution-wrap></funding-source><award-id>Summer Scholarship</award-id><principal-award-recipient><name><surname>Riboni-Verri</surname><given-names>Gioia</given-names></name></principal-award-recipient></award-group><funding-statement>The authors declare that the funders provided research equipment and laboratory consumables, as well as salary support for Julia Schaeffer, Eleanor Walder and Gioia Riboni-Verri.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The nerve growth-repellent activity that generates spinal nerve repeat-patterning in birds and mammals is identified at the molecular level, and a similar system is revealed in adult brain grey matter.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Peripheral spinal nerves have a striking anatomical periodicity, or segmentation, that reflects their necessary isolation from the segments of developing bone that will form the vertebral column. This study sets out to identify the molecular basis of this patterning. We find a critical role for the enzyme protein disulphide isomerase in separating outgrowing axons from the somite cells that generate the vertebrae, and provide evidence regarding the underlying mechanism (<xref ref-type="bibr" rid="bib16">Cook et al., 2019</xref>).</p><p>In avian and mammalian embryos, both outgrowing motor and sensory axons, and migrating neural crest cells, encounter the periodic somites that flank both sides of the neural tube (future spinal cord). Here they traverse preferentially the anterior (A, rostral/cranial) - rather than posterior (P, caudal) - halves of each successive somite (<xref ref-type="bibr" rid="bib43">Keynes and Stern, 1984</xref>; <xref ref-type="bibr" rid="bib63">Rickmann et al., 1985</xref>; <xref ref-type="bibr" rid="bib12">Bronner-Fraser, 1986</xref>; <xref ref-type="bibr" rid="bib24">Fleming et al., 2015</xref>; <xref ref-type="fig" rid="fig1">Figure 1a</xref>). For neural crest cells this preference has been shown to depend on repulsive signalling in the P-half-somite by members of the Semaphorin/Neuropilin- and Ephrin/Eph protein families (<xref ref-type="bibr" rid="bib46">Krull et al., 1997</xref>; <xref ref-type="bibr" rid="bib80">Wang and Anderson, 1997</xref>; <xref ref-type="bibr" rid="bib44">Koblar et al., 2000</xref>; <xref ref-type="bibr" rid="bib27">Gammill et al., 2006</xref>; <xref ref-type="bibr" rid="bib19">Davy and Soriano, 2007</xref>; <xref ref-type="bibr" rid="bib67">Schwarz et al., 2009</xref>). However the basis of axonal segmental patterning has remained elusive.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Identification of csPDI in somites.</title><p>(<bold>a</bold>) Schematic diagram of two spinal nerve segments in the early embryo of birds and mammals. The neural tube (future spinal cord) extends longitudinally, overlying the midline notochord (future intervertebral discs); anterior/A (cranial/rostral) to the left and posterior/P (caudal) to the right. Two somites are shown, each sub-divided into 2 main components - the dermomyotome (future dermis and skeletal muscle) and sclerotome (future vertebral cartilage and bone). The sclerotome of each somite is further subdivided longitudinally into A- and P-halves (dashed lines), and the early components of the peripheral nervous system develop within the mesenchyme of each successive A-half-sclerotome. Here, motor axons (green) extend from cell bodies in the ventral (V) neural tube, and sensory axons (red) extend from cell bodies that coalesce to form the dorsal root ganglion (DRG). The DRGs derive from neural crest cells that earlier migrated into the A-half-sclerotomes (thick arrows) from the dorsal neural tube (<bold>D</bold>). Each DRG cell body generates one axon that grows dorsally to enter the neural tube and one that grows ventrally to join the motor axons; together with preganglionic autonomic axons (not shown), these motor and sensory axons form the 'mixed' spinal nerves that will innervate the body at each segmental level. Scale bar 50 μM. Adapted from <xref ref-type="bibr" rid="bib47">Kuan et al., 2004</xref>. (<bold>b</bold>) Silver-stained SDS-PAGE of lactose eluate of chick somite proteins bound to PNA-agarose; arrow indicates the major band of 57 kDa. (<bold>c, d</bold>) Somite strip live-stained with rhodamine-PNA (red, (<bold>b</bold>) and co-stained with fluorescein-conjugated anti-PDI; preferential staining of three P-half-sclerotomes is shown; PNA staining and anti-PDI staining are co-localized (yellow, (<bold>c</bold>); vertical white lines indicate half-somite boundaries; Scale bars 50 μM. (<bold>e-g</bold>), Higher magnification of boxed regions in c and d showing ring staining at the cell periphery by rhodamine-PNA (<bold>d</bold>) and by fluorescein-conjugated anti-PDI (<bold>e</bold>), and their co-localisation (yellow, (<bold>f</bold>). Scale bars 5 μM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Further characterisation of csPDI in somites.</title><p>(<bold>a</bold>) Identification of csPDI in somites by mass spectrometry. The major band seen in <xref ref-type="fig" rid="fig1">Figure 1a</xref> (arrow) was carefully excised and dispatched to Alta Bioscience (UK) for tryptic digestion and examination by mass spectrometry. The 57-peptide tryptic digest amino acid sequences correspond to chicken PDI, subtype PDIA1 or P4HB. (<bold>b</bold>) Reductase activity in purified PDI. Three concentrations of purified PDI (Sigma-Aldrich; 128 nM, 64 nM, 32 nM) were examined for reductase activity using dieosin glutathione disulphide (Di-E-GSSG). Two-way analysis of variance and multiple comparisons using the Bonferroni test showed no significant difference between the upper curves (blue and red; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). This is in accord with the carbohydrate composition of this enzyme preparation. Bovine liver PDI is a glycoprotein with 12% by weight of carbohydrate; L-fucose and N-acetylgalactosamine are not present in detectable quantities (<xref ref-type="bibr" rid="bib13">Carmichael et al., 1977</xref>). The lack of the latter sugar indicates that O-glycosylation is not a feature of this liver enzyme. (<bold>c</bold>) Onset of csPDI expression in somites. A parasagittal section (10 μM) showing a somite with its A- and P-halves flanked on each side by adjacent half-somites, stained for csPDI using fluorescein-conjugated PNA (green), and for the first emerging spinal axons (red, thick arrows) using TUJ1 antibody; thin arrows indicate the somite boundaries; axons emerge from the neural tube in the A-half of the somite (A), and PNA-staining is visible in the P-half (P). NT, neural tube. Scale bar 40 μM. (<bold>d</bold>) Onset of csPDI expression in 11 stage 16/17 chick embryos (26–32 somites), assessed using 10 μM parasagittal sections of somites stained with fluorescein-conjugated PNA; the X-axis and upper schematic diagram show the somite positions (11, 12, 13) where PNA-staining was first detected in individual embryos, counting somites in a P-A (left-right) direction (most recently formed somite = 1). The first emerging spinal axons (stained using TUJ1 antibody) either coincided with the onset of PNA staining (1/11 embryos), or were delayed by the time taken to form one more somite (9/11 embryos) or two more somites (1/11 embryos). Since each somite takes ~90 min to form, csPDI expression precedes axon outgrowth in each segment by ~90–180 min.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig1-figsupp1-v3.tif"/></fig></fig-group><p>We previously identified contact repulsion as the main cellular mechanism generating axonal patterning (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>; <xref ref-type="bibr" rid="bib42">Keynes et al., 1997</xref>). Sequential repulsion of outgrowing motor and sensory axons in successive P-half-sclerotomes (future vertebrae) forces axons to traverse the anterior (A/cranial) halves. We showed that extracts of chick embryo somites cause growth cone collapse of both motor and sensory axons in vitro (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>), a phenomenon that is widely used as a method for identifying molecules that regulate growth cone motility (<xref ref-type="bibr" rid="bib40">Kapfhammer and Raper, 1987</xref>; <xref ref-type="bibr" rid="bib60">Raper and Kapfhammer, 1990</xref>). Additionally we found that the lectins peanut agglutinin (PNA) and jacalin bind selectively to the surface of P-half-sclerotome cells rather than A-half-sclerotome cells (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>; <xref ref-type="bibr" rid="bib74">Stern et al., 1986</xref>). Immobilized PNA can be used to deplete collapse activity, and activity is recovered by lactose elution. Biochemical purification led to the identification of two PNA-binding glycoproteins shown by SDS-PAGE as two silver staining bands of 48 kDa and 55 kDa (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of cell surface PDI in somites</title><p>In the present work we combined PNA affinity purification with more effective inhibition of protease activity in the somite extracts, and examined the lactose eluates by semi-preparative SDS PAGE. This revealed a major silver-staining band of apparent molecular weight 57 kDa, closely matching the 55 kDa band seen in the earlier study (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>; <xref ref-type="fig" rid="fig1">Figure 1b</xref>). The band was excised and submitted for tryptic digestion and mass spectrometry, revealing 57 peptides distributed throughout the extent of the enzyme protein disulphide isomerase/PDIA1/P4HB (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>).</p><p>PDIA1/P4HB is one of a PDI-family of proteins that share in common a thioredoxin-like structural fold (<xref ref-type="bibr" rid="bib45">Kozlov et al., 2010</xref>). It is known principally as an intracellular enzyme localized in the endoplasmic reticulum (ER), where it regulates protein folding by catalyzing the formation and breakage of disulphide bonds (<xref ref-type="bibr" rid="bib30">Goldberger et al., 1963</xref>; <xref ref-type="bibr" rid="bib2">Ali Khan and Mutus, 2014</xref>; <xref ref-type="bibr" rid="bib54">Parakh and Atkin, 2015</xref>). A PDIA1-related molecule was also identified previously as a retina-specific candidate cell adhesion molecule (<xref ref-type="bibr" rid="bib33">Hausman and Moscona, 1975</xref>; <xref ref-type="bibr" rid="bib55">Pariser et al., 2000</xref>). Our finding that somite cell surface PDI (csPDI) binds PNA, and is lactose-elutable from immobilized PNA, indicates that this form of PDI is O-glycosylated. This is supported by the observation that csPDI expressed by Jurkat T cells, immortalized from human T cell leukaemia, also possesses PNA-binding O-glycans, the elongation of which can be blocked experimentally (<xref ref-type="bibr" rid="bib8">Bi et al., 2011</xref>; <xref ref-type="bibr" rid="bib65">Schaefer et al., 2017</xref>). In addition, using a sensitive fluorescent reductase assay (<xref ref-type="bibr" rid="bib61">Raturi and Mutus, 2007</xref>) we found that commercially purified (bovine liver) PDI does not bind to PNA-agarose, indicating that somite csPDI has an affinity for PNA based on its glycosylation state (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>). The expression of PDI at the surface of P-half-sclerotome cells was confirmed by live-staining of microdissected strips of chick somites, using both polyclonal anti-PDI antibody and fluorescently labelled PNA, which showed co-localization at the cell periphery in the P-half-sclerotome (<xref ref-type="fig" rid="fig1">Figure 1c–g</xref>). Also the onset of PNA staining in the P-half-sclerotome was found to precede the first emergence of motor and sensory axon outgrowth in the A-half-sclerotome by ~1.5–3 hr (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c,d</xref>).</p></sec><sec id="s2-2"><title>csPDI mediates spinal nerve patterning in vivo</title><p>A role for csPDI in mediating repulsion of outgrowing spinal axons in vivo was tested by siRNA knockdown of csPDI expression in chick embryo somites in ovo, predicted to promote outgrowth of motor and sensory axons into the P-half-sclerotomes. A construct was designed on the basis of the study of <xref ref-type="bibr" rid="bib87">Zai et al., 1999</xref>. They used an antisense oligodeoxynucleotide directed against a 24 base pair target sequence in the 3' UTR of PDIA1/P4HB to show that csPDI expression in human erythroleukaemia cells is markedly reduced (&gt;70%) without significantly affecting cell viability. The efficacy and specificity of this construct has also been shown by others (<xref ref-type="bibr" rid="bib72">Sobierajska et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Janiszewski et al., 2005</xref>). We initially confirmed that the chick siRNA construct inhibits expression of csPDI in primary cultures of chick retinal cells and P-half-sclerotome cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a–d</xref>). PDI gene knockdown in ovo was then carried out by microinjection of the siRNA, incorporated in a polyethylene glycol matrix, into at least 8 somites on one side of the embryo, anterior to the most recently formed somite (stage 9–12 <xref ref-type="bibr" rid="bib32">Hamburger and Hamilton, 1951</xref>; <xref ref-type="fig" rid="fig2">Figure 2a</xref>). Confirmation of cs-PDI knockdown using Western blotting was not attempted due to the limiting availability of sufficient quantities of somite tissue, combined with the high ratio of constitutive PDI expression in the ER versus csPDI. As predicted however, PDI knockdown in ovo caused loss of extracellular PNA-binding in P-half-sclerotomes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1e–g</xref>). After siRNA injection and further incubation for 48 hr, spinal nerve outgrowth was assessed by immunohistochemistry using a neuron-specific-β-III tubulin antibody (clone TUJ1), observer-blind to treatment condition. Embryos treated with control/scrambled siRNA showed normal axon segmentation, with growth restricted to the A-half-sclerotomes (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). However PDI knockdown caused outgrowing motor axons to project additionally into the P-half-sclerotomes adjacent to the neural tube/spinal cord (<xref ref-type="fig" rid="fig2">Figure 2c,d</xref>), an abnormal trajectory not seen in untreated embryos or in those similarly treated with control/scrambled siRNA. Control experiments showed that expression of the A-half-somite polarity determinant gene <italic>Tbx18</italic> was unaffected by siRNA injection, whereas expression of the P-half determinant gene <italic>Uncx4.1</italic> was variably diminished in the treated region (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1h</xref>). Since <italic>Tbx18</italic> expression did not alter correspondingly, this was unlikely to be due to a P-to-A switch in cell identity, or to reflect a change in cell viability due to reduced PDI expression. It may be explained if csPDI knockdown in P-half-sclerotome cells at the A/P boundaries causes some to mix with neighbouring A-half cells and down-regulate <italic>Uncx4.1</italic> expression as a result. Injection of scrambled siRNA did not cause detectable sclerotome caspase-3 expression.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>csPDI mediates nerve patterning in vivo.</title><p>(<bold>a</bold>) Image of a live embryo in ovo, viewed from above, taken 24 hr after injection of fluorescein-labelled siRNA into somites (arrows) on one side; label is distributed throughout the A- and P-half-sclerotomes of each somite, and is visibly diminished, as expected, at 3 consecutive somite boundaries. Scale bar 100 μM. (<bold>b</bold>) Representative image of normal motor axon segmentation following scrambled siRNA delivery. Longitudinal section stained using fluorescein-conjugated TUJ1 antibody. Scale bar 100 μM. (<bold>c, d</bold>) Loss of axon segmentation in two embryos after PDI siRNA knockdown. The siRNA-treated side of each embryo is shown; axons are segmented normally (left) but this is disrupted (right) where axons grow into P-half-sclerotomes (P). NT, neural tube. Scale bars 100 μM. (<bold>e, f</bold>) Loss of axon segmentation in embryos after in ovo implantation of PACMA 31-impregnated bead (blue); embryos were stained using HRP-labelled TUJ1 antibody and viewed as whole-mounts (<bold>e</bold>) or as implanted-side-only half-mounts (<bold>f</bold>); abnormal growth of sensory axons (arrow, e; upper arrow, f) towards dorsal neural tube (dNT) in P-half-sclerotome (P’), compared with normal projections avoiding two adjacent P-half-sclerotomes (P, P’’); lower arrow (f) indicates motor axons sprouting from ventral neural tube (vNT) into P-half-sclerotome; asterisks, spinal axons on opposite side of whole-mount (<bold>e</bold>). Scale bars 150 μM. (<bold>g</bold>) Normal segmentation of dorsal/sensory axons and ventral/motor axons after implantation of PACMA 56 bead; P, P’, P’’, dorsal and ventral domains of 3 consecutive P-half-sclerotomes. Scale bar 150 μM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Phenotypic rescue of siRNA knockdown and effect of inhibiting csPDI using PACMA 31.</title><p>(<bold>a</bold>) Chick retinal cells after transfection with scrambled siRNA, stained with anti-PDI antibody (red) and the nuclear marker DAPI (blue). Scale bar 10 μM. (<bold>b</bold>) Stained as in a, after PDI knockdown using FITC-siRNA (green). Scale bar 10 μM. (<bold>c, d</bold>) P-half-sclerotome cells showing PDI expression (red) after transfection with scrambled FITC-siRNA (green) (<bold>c</bold>), and loss of PDI expression after knockdown with FITC-siRNA (green; <bold>d</bold>). Scale bar 10 μM. (<bold>e</bold>) Somite strip after injection of control scrambled siRNA, showing normal PNA expression in 5 P-half-sclerotomes along the A-P axis. P-half-sclerotome, P; Dermomyotome, DM; neural tube, NT. Scale bar 50 μM. (<bold>f, g</bold>) Somite strips stained for PNA after siRNA PDI knockdown. <bold>f</bold>, loss of PNA staining in three consecutive P-half-somites (left) compared with two normally stained P-half-somites (right); P, P-half-sclerotome; <bold>g</bold>, loss of PNA staining in two segments with residual spots of FITC-siRNA expression (arrows). Scale bars 50 μM. (<bold>h</bold>) Left, sagittal section of a stage 22 siRNA-transfected embryo, hybridized with a <italic>Tbx18</italic> probe; regional expression in A-half-somites is unaltered. Scale bar 100 μM. Right, stage 22 PDI-siRNA transfected whole-mounted embryo, hybridized with an <italic>Uncx4.1</italic> probe, showing diminished expression in 3 P-half-sclerotomes (arrows). Scale bar 100 μM. (<bold>i</bold>) Rescue of siRNA-induced ventral root/motor axon phenotype by co-injection in ovo of siRNA with PDI-expressing plasmid (1 μg or 2 μg as indicated). For each histogram bar, 10 consecutive somites in the injected region of each embryo were assessed (observer-blind to treatment condition) for the presence or absence of motor axons projecting abnormally into P-half-somite, using anti-TUJ1-HRP-stained whole-mounted embryos. (<bold>j</bold>) Sclerotome cells stained with HRP-labelled anti-PDI antibody in a whole-mounted embryo that received co-injected siRNA and plasmid (1 μg). Scale bar 5 μM. (<bold>k</bold>) Sclerotome cells stained with fluorescein-conjugated anti-FLAG-M1 antibody in a whole-mounted embryo that received co-injected siRNA and plasmid (1 μg). Scale bar 5 μM. <bold>l</bold>, PACMA 31 (200μM administered by direct injection to somites on one side in ovo) caused a significant increase in aberrant motor/ventral root axon sprouting compared with PACMA 56 injection. (<bold>m</bold>) PACMA 31 (200μM by direct injection in ovo) resulted in dorsal 'bridges' of sensory axons (arrows) interconnecting adjacent axon bundles, contrasting with the normal dorsal/sensory axon segmentation on the non-injected side (NT, neural tube; P, P-half-sclerotome). Scale bar 100 μM. (<bold>n</bold>) PACMA 31 (200μM by direct injection in ovo) showing the incidence of dorsal bridges of sensory axons in PACMA 31-injected embryos compared with their absence in PACMA 56-injected embryos (P56). (<bold>o</bold>) Assessment of ventral root A-P width after PACMA injection (200 μM) into somites in ovo. Sections of stage-21 TUJ1-stained embryos were blind-coded and assessed by fluorescence microscopy. Images were taken with QCapture Pro 6.0 and analyzed with ImageJ, measuring the A-P width of the ventral root at the most proximal position where constituent motor axons align in parallel (schematic inset upper right, above dashed line); n = 12 embryos (PACMA31), n = 9 embryos (PACMA56), n = 10 embryos (untreated).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig2-figsupp1-v3.tif"/></fig></fig-group><p>To rule out the possibility that these phenotypes resulted from an off-target effect of the siRNA, control experiments confirmed that co-injection of siRNA with a FLAG-M1-epitope-tagged plasmid expressing human PDIA1/P4HB (&gt;90% homologous to chicken PDIA1 <xref ref-type="bibr" rid="bib23">Everson and Kao, 1997</xref>) partially rescued the normal segmented axon phenotype (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1i–k</xref>). We also found that inhibiting the enzyme activity of PDI caused a similar phenotype. PDI possesses two independent active sites, and the small molecule PACMA 31 has been shown to form a covalent bond with a cysteine residue of the second active site, thereby inhibiting its catalytic activity (<xref ref-type="bibr" rid="bib86">Xu et al., 2012</xref>). PACMA 31 was applied in ovo using two delivery methods. First, as described above for siRNA delivery, PACMA 31 in solution (200 μM) was injected directly into somites in ovo and the resulting axon phenotype assessed by immunohistochemistry. PACMA 56, an inactive substituted alkynyl derivative of PACMA 31 that does not bind to PDI (<xref ref-type="bibr" rid="bib86">Xu et al., 2012</xref>), acted as a control. Consistent with the results of siRNA knockdown, PACMA 31 injection also caused abnormal axon projections into P-half-sclerotome whereas control/PACMA 56 injection did not (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1l–n</xref>). In addition the A-P width of ventral roots increased after PACMA 31 injection, indicating axon defasciculation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1o</xref>).</p><p>The second PACMA delivery method involved impregnation of Affi-Gel Blue agarose beads (25–50 μm diameter) with PACMA 31 or PACMA 56 (500μM), followed by microsurgical implantation of single beads in ovo between the neural tube and newly-formed sclerotome in stage 12–14 chick embryos. After further incubation for 24–36 hr, axon trajectories were assessed in the implant region by whole-mount immunohistochemistry. As with siRNA knockdown, PACMA 31 caused abnormal axon outgrowth into P-half-somite territory (<xref ref-type="fig" rid="fig2">Figure 2e,f</xref>; 14/29 embryos). Using PACMA 56 as control, only an occasional axon outgrowth abnormality (1/20 embryos) was observed; in 19/20 embryos, axons were confined to the A-half-sclerotomes as in normal embryos (<xref ref-type="fig" rid="fig2">Figure 2g</xref>).</p></sec><sec id="s2-3"><title>csPDI mediates axon repulsion via nitric oxide signalling/S-nitrosylation</title><p>To elucidate the mechanism of action of csPDI we first tested whether PDI causes growth cone collapse by direct interaction with the growth cone surface. The purified bovine enzyme incorporated in liposomes was added at a range of concentrations (25–1000 ng/ml) to cultures of chick embryo dorsal root ganglia (DRGs) extending sensory axons on laminin in the presence of nerve growth factor (NGF; typically between 50 to &gt;100 growth cones were assayed per DRG). However this did not increase collapse above the control levels (0–20% of growth cones) seen after addition of phosphate-buffered saline (PBS) or untreated liposomes (<xref ref-type="fig" rid="fig3">Figure 3a</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>csPDI mediates axon repulsion in vitro.</title><p>(<bold>a</bold>) Collapse assays testing purified bovine PDI in liposomes at a range of concentrations; controls, phosphate-buffered saline (PBS) and untreated liposomes; histogram shows mean + s.e.m. (<bold>b</bold>) Assays testing PDI and GSNO applied individually or concomitantly. (<bold>c</bold>) Assays testing PACMA31 and PACMA56 on somite extracts (SE). (<bold>d</bold>) Assays testing reducing agents at the concentrations indicated when applied either alone or together with PDI+GSNO. (<bold>e</bold>) Assays testing GSH and L-homocysteine on SE-induced collapse. (<bold>f</bold>) Assays testing myoglobin (20 μM) on SE- and PDI+GSNO-induced collapse. (<bold>g</bold>) Assays testing carboxy (C)-PTIO (20 μM) on PDI+GSNO-induced collapse. (<bold>h</bold>) Assays testing L-NAME and its control D-NAME on SE-induced collapse; calcimycin was used as a positive control. (<bold>i</bold>) S-nitrosylated protein (iodo-TMT-labelled) in somites; protein samples (48 μg) from somite cell-free extracts were fractionated on NuPAGE 4–12% Bis Tris gels as described in the Methods; lanes 1 and 2 are controls consisting of somite proteins only, with no detectable signal compared with lanes 3 and 4 where GSNO has been added; lane 3 is a control (treated with water) showing negligible iodoTMT labelling, and lane 4 (reduced with ascorbate to generate a new free thiol for labelling) shows increased label; lane 5 shows that addition of PDI (1 μg/0.1 ml reaction mixture) enhances labelling; lane 6 shows that 3 mM GSH in the absence of GSNO and PDI does not generate a signal; lane 7 shows that 3 μM GSH is insufficient to interfere with nitrosylation, concurring with the findings of <xref ref-type="bibr" rid="bib71">Sliskovic et al., 2005</xref>. The coloured molecular weight markers on the blot are shown on the left (BLUeye prestained protein ladder, 2.5 μL, Geneflow). (<bold>j</bold>) Identification of LC1 in somite extract (25 μg protein); the blot was cut in half above the 41K marker and the top half of the membrane was probed with rabbit anti-tubulin followed by goat anti-rabbit IgG; the bottom half was probed with mouse monoclonal antibody against amino acids 2257–2357 of mouse MAP-1B (LC1) followed by goat anti-mouse IgG. The molecular weight markers on the blot are shown to the right (BLUeye prestained protein ladder, 3 μl). (<bold>k</bold>) Identification of LC1 as a substrate for S-nitrosylation; cell-free somite extract (200 μg) was treated with D-NAME or L-NAME, followed by further incubation in GSNO (200 μM), as described in the Methods. Samples were then processed for the presence of S-nitrosylated proteins using iodo-TMT as described in the Methods. Protein samples (15 μg) were then fractionated and blotted, after which the blot was cut as described for (<bold>j</bold>). The top half was treated with anti-tubulin and the bottom half with anti-iodoTMT. L-NAME treatment blocked S-nitrosylation, as shown by the lack of iodoTMT labelling. The control D-NAME was without effect.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Additional characterisation of csPDI-mediated growth cone collapse.</title><p>(<bold>a-c</bold>) Comparison of collapse induced by PDI+GSNO either in solution (<bold>a,b</bold>) or in liposomes (<bold>c</bold>) when PDI is applied at a range of concentrations together with GSNO (1 μM). Panel b (left-half) shows the predominantly spread growth cones in an untreated/control culture, compared with a representative phase-contrast image of 3 collapsed growth cones (right-half, arrows) 1 hr after addition of PDI+GSNO in solution. Scale bars 15 μM. (<bold>d-f</bold>) Comparison of collapse time course after applying PDI (125 ng/ml) and GSNO (1 μM) in solution (<bold>d</bold>), after SE in liposomes (<bold>e</bold>), and after Sema3A (<bold>f</bold>). g-l, Assays testing purified bacitracin (<bold>g</bold>), anti-PDI neutralizing antibody (<bold>h,i</bold>), PAO (<bold>j</bold>), T3 (<bold>k</bold>) and 16F16 (<bold>l</bold>) on PDI+GSNO-induced collapse.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig3-figsupp1-v3.tif"/></fig></fig-group><p>Nitric oxide (NO) has been shown to elicit growth cone collapse in vitro when released in solution from NO donors [3-morpholino-sydononimine, SIN-1 (<xref ref-type="bibr" rid="bib35">Hess et al., 1993</xref>); also 3-(2-hydroxy-1- methyl-2-nitrosohydrazino)-<italic>N</italic>-methyl-1-propanamine, NOC-7 (<xref ref-type="bibr" rid="bib22">Ernst et al., 2000</xref>; <xref ref-type="bibr" rid="bib34">He et al., 2002</xref>). Moreover <xref ref-type="bibr" rid="bib87">Zai et al., 1999</xref> have shown that NO entry into csPDI-expressing human erythroleukemia cells involves a transnitrosation mechanism catalyzed by the enzyme. Physiological NO donor S-nitrosothiol (SNO) levels have been estimated in human cerebrospinal fluid and plasma at low micromolar concentrations (respectively 0.86 ± 0.04 μM <xref ref-type="bibr" rid="bib5">Bayir et al., 2003</xref> and 1.77 ± 0.32 µM <xref ref-type="bibr" rid="bib50">Massy et al., 2003</xref>). We therefore tested whether application of PDI in combination with S-nitrosoglutathione (GSNO, 1 µM) as NO donor causes growth cone collapse. Whereas application of GSNO alone in solution did not elicit collapse above control levels, significant collapse was observed when GSNO was first combined with PDI (125 ng/ml) and then added to DRG cultures (~60% growth cones collapsed after 1 hr, <xref ref-type="fig" rid="fig3">Figure 3b</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a,b</xref>). To confirm that PDI+GSNO-induced collapse in solution is reproduced in the liposome-based collapse assay, we found that the PDI concentration dependence of collapse was similar in both cases. (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a,c</xref>). Also the time course of PDI+GSNO-induced collapse was similar to that induced by somite extracts, and contrasted with the more rapid onset of collapse induced by the soluble repellent Sema3A (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1d–f</xref>).</p><p>We next tested the PDI inhibitors purified-bacitracin (<xref ref-type="bibr" rid="bib64">Rogelj et al., 2000</xref>), anti-PDI neutralizing antibody, phenylarsine oxide (PAO) (<xref ref-type="bibr" rid="bib7">Bennett et al., 2000</xref>), acetylated triiodothyronine (T3) (<xref ref-type="bibr" rid="bib57">Primm and Gilbert, 2001</xref>) and 16F16 (<xref ref-type="bibr" rid="bib36">Hoffstrom et al., 2010</xref>) on PDI+GSNO-induced collapse when applied in solution. Of these, three inhibitors (bacitracin, neutralizing antibody and PAO) were most effective in reducing collapse when incorporated in liposomes with PDI (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1g–l</xref>). Following the publication of the small molecule PDI-inhibitor PACMA 31 and its control PACMA 56 (<xref ref-type="bibr" rid="bib86">Xu et al., 2012</xref>), the candidacy of csPDI in mediating somite extract (SE)-induced collapse was further confirmed using PACMA 31 in liposomes, which inhibited collapse by &gt;50% whereas PACMA 56 was inactive (<xref ref-type="fig" rid="fig3">Figure 3c</xref>).</p><p>PDI has two active sites, each with the amino acid sequence WCGHCK. <xref ref-type="bibr" rid="bib71">Sliskovic et al., 2005</xref> have shown that PDI can be S-nitrosylated (PDI-SNO), and that the enzyme can also act as a denitrosylase resulting in •NO release as a free radical. They have proposed that PDI-SNO is denitrosylated by a one-electron reduction mechanism at the second active site. Moreover they showed that glutathione (GSH) is the most effective reducing agent, and that no significant denitrosylation is observed using reducing agents dithiothreitol (DTT) or L-homocysteine (<xref ref-type="bibr" rid="bib71">Sliskovic et al., 2005</xref>). Consistent with their study, we found that when PDI+GSNO or somite extracts were incorporated in liposomes and subsequently treated with GSH (3 mM), collapse activity was lost. However identical experiments using 3 mM DTT or L-homocysteine did not affect collapse activity. Notably, GSH did not block collapse when applied at 3 µM, within the extracellular concentration range typically present in vivo and 3 orders of magnitude below the ambient intracellular concentration range (<xref ref-type="bibr" rid="bib52">Owen and Butterfield, 2010</xref>; <xref ref-type="fig" rid="fig3">Figure 3d</xref>; see Discussion). Also consistent with the observations of <xref ref-type="bibr" rid="bib71">Sliskovic et al., 2005</xref>., somite extract-induced collapse was inhibited by 3 mM GSH but not by 3 mM L-homocysteine (<xref ref-type="fig" rid="fig3">Figure 3e</xref>).</p><p>Further evidence that a NO-based mechanism elicits growth cone collapse was provided by the finding that myoglobin, regarded as a pseudo-enzymatic NO scavenger (<xref ref-type="bibr" rid="bib3">Ascenzi and Brunori, 2001</xref>; <xref ref-type="bibr" rid="bib62">Rayner et al., 2009</xref>), inhibited collapse induced by PDI+GSNO and by somite extracts (<xref ref-type="fig" rid="fig3">Figure 3f</xref>). PDI+GNSO-induced collapse was also inhibited by the membrane-impermeable NO-scavenger carboxy-2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (C-PTIO; <xref ref-type="fig" rid="fig3">Figure 3g</xref>). Somite extract-induced collapse was additionally prevented by pre-treatment of DRGs with the neuronal nitric oxide synthase (nNOS) inhibitor L-NAME, but not by its control/chiral isomer D-NAME, indicating a role for nNOS activity in the collapse process (<xref ref-type="fig" rid="fig3">Figure 3h</xref>).</p><p>These experiments implicate NO signalling in somite-induced growth cone repulsion. The in vitro study of <xref ref-type="bibr" rid="bib76">Stroissnigg et al., 2007</xref> has likewise shown a role for S-nitrosylation of the microtubule-associated protein MAP1B in mediating mouse DRG growth cone collapse caused by stimulation of nNOS by the calcium ionophore calcimycin/A23187. They showed further that S-nitrosylation of Cys 2457 in the MAP1B light chain sub-unit (LC1) is a critical event in the cytoskeletal dynamics underlying collapse. To examine expression of S-nitrosylated proteins in somites, we therefore carried out Western blotting of cell-free somite extracts using iodoTMT reagent, which gives lower background labelling compared with biotin labelling. The assay was prepared from 650 dissected somite strips homogenised in HENS buffer. Remarkably only one major band (molecular weight 38 kDa) was detectably S-nitrosylated (<xref ref-type="fig" rid="fig3">Figure 3i</xref>). We additionally confirmed, by Western blotting using a mouse monoclonal antibody against amino acids 2257–2357 in LC1 of mouse MAP-1B (see Materials and methods), that this S-nitrosylated somite protein reacts strongly with the anti-LC1 antibody (<xref ref-type="fig" rid="fig3">Figure 3j</xref>). Also the nNOS inhibitor L-NAME inhibited both S-nitrosylation of the 38 kDa protein (<xref ref-type="fig" rid="fig3">Figure 3k</xref>) and somite extract-induced growth cone collapse (<xref ref-type="fig" rid="fig3">Figure 3h</xref>), while the control stereoisomer D-NAME was without effect (<xref ref-type="fig" rid="fig3">Figure 3h,k</xref>). These findings indicate that a molecular mechanism similar to that proposed by <xref ref-type="bibr" rid="bib76">Stroissnigg et al., 2007</xref> operates within the growth cone during its repulsion by somites in vivo.</p></sec><sec id="s2-4"><title>csPDI activity in mammalian forebrain grey matter</title><p>We previously found that, as for somites, extracts of adult mammalian and chicken forebrain grey matter also cause sensory/DRG axon growth cone collapse that can be depleted by the use of immobilized PNA. This suggested that a contact-repulsive system similar to that in somites may be expressed in the mature CNS (<xref ref-type="bibr" rid="bib41">Keynes et al., 1991</xref>). In confirmation we found that immobilized jacalin, a lectin that binds the same O-linked disaccharide (Galβ1-3GalNAc) as does PNA, but unlike PNA is not selective for its de-sialylation, can be used to deplete collapse induced by rat forebrain extracts (RFE; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a</xref>). <xref ref-type="bibr" rid="bib28">Ghosh and David, 1997</xref> have also described a growth cone collapse-inducing activity in membrane preparations of rat cerebral cortical grey matter. We therefore tested whether, as for somite extracts, a range of inhibitors of PDI activity block RFE-induced collapse, and found this was the case. Application of PACMA 31 (5μM) significantly reduced collapse (by 50–60%) whereas PACMA 56 (5μM) did not (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1b</xref>). Another small molecule PDI-inhibitor, quercetin-3-O-rutinoside (<xref ref-type="bibr" rid="bib39">Jasuja et al., 2012</xref>) inhibited RFE-induced collapse when used at both 1 μM and 50 μM (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). RFE-induced collapse activity was immunodepleted using polyclonal anti-PDI antibody but not using IgG or bovine serum albumin (BSA) as sham protein controls (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Moreover, as for somite extracts, application of 3 mM GSH reduced RFE-induced growth cone collapse, whereas 3 mM DTT, 3 mM L-homocysteine (L-HC) or 3 μM GSH did not (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). At GSH concentrations between 3 μM and 3 mM, inhibition of collapse increased with concentration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1c</xref>). Last, and again consistent with a NO-based mechanism, we confirmed that application of the NO scavengers myoglobin and C-PTIO depleted RFE-induced collapse (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1d,e</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>csPDI activity in mammalian forebrain.</title><p>(<bold>a-d</bold>) Collapse assays using PACMA 31 and PACMA 56 (<bold>a</bold>), quercetin-3-O-rutinoside (<bold>b</bold>), immunodepletion (<bold>c</bold>), and reducing agents (<bold>d</bold>). (<bold>e</bold>) Immunocytochemistry on live human astrocytic (1718) cells. Scale bars 20 μM. Row 1, anti-PDI (red) shows PDI expression at the cell surface, DAPI-staining (blue) shows position of nucleus. Row 2, anti-PDI live staining at the cell surface (red) contrasts with selective staining of ER with ER-Tracker (green). Rows 3,4, fixation permits visualisation of ER-PDI using anti-calnexin (green), which is absent under live staining conditions (Row 5).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Action of lectins and other reagents on collapse activity in brain/astrocyte extracts and responsivity of retinal neurons.</title><p>(<bold>a</bold> ) Collapse assays showing depletion of collapse activity in rat forebrain extract (RFE) by use of immobilized jacalin; immobilized BSA was used as an additional control. (<bold>b</bold>) Collapse assays showing quantification of PACMA31 dose/response relationship. (<bold>c</bold>) Collapse assay and GSH titration. (<bold>d</bold>) Collapse assays testing the NO scavenger myoglobin (20 μM). (<bold>e</bold>) Collapse assays testing the NO scavenger C-PTIO. (<bold>f</bold>) Collapse assays using dialysed extracts from human 1718 astrocytic cells, testing activity before and after depletion by immobilized PNA and jacalin; immobilized BSA was used as an additional control. (<bold>g</bold>) Western blot of rat cortical astrocyte cell surface preparation using anti-PDI antibody, showing one band at 57 KDa in the centre of the blot. The doublet (right) is control purified bovine PDI (500 ng), and the lower band indicates that this control sample was partially oxidised. Molecular weight markers (10 μl; BLUeye Prestained Wide Range Protein ladder, Geneflow) are shown (left), transferred from the gel to the blot. (<bold>h</bold>) Collapse assays testing reactivity of chick retinal axon growth cones to PDI+GSNO.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig4-figsupp1-v3.tif"/></fig></fig-group><p>One source of csPDI in the brain may be the astrocyte, which shares fate specification by the transcription factor SOX9 with P-half-sclerotome cells (future vertebral cartilage) (<xref ref-type="bibr" rid="bib1">Akiyama et al., 2002</xref>; <xref ref-type="bibr" rid="bib75">Stolt et al., 2003</xref>; <xref ref-type="bibr" rid="bib77">Sun et al., 2017</xref>). In support of this, live-staining experiments showed that csPDI is expressed on the surface of cultured human astrocytic cells, as for P-half-sclerotome cells (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). Moreover extracts of these cells caused growth cone collapse that was removed by the use of immobilized PNA and jacalin (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1f</xref>), and a cell surface preparation isolated from rat primary cortical astrocytes was found to contain csPDI (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1g</xref>).</p><p>Collectively these experiments indicate that csPDI is a major component of the growth cone collapse-inducing activity detectable in the grey matter of the mature mammalian brain. The NGF-dependent primary sensory neurons assessed here project axons in vivo in the CNS as well as PNS, making synapses in the dorsal horn of the spinal cord and in the brainstem. We have shown previously that two populations of CNS-restricted neurons are also responsive to the somite contact-repellent system. When explants of embryonic day-4 (E4) chick telencephalon or E7 retina are grafted in ovo in place of chick spinal cord, their axons avoid P-half-somites (<xref ref-type="bibr" rid="bib41">Keynes et al., 1991</xref>; <xref ref-type="bibr" rid="bib79">Vermeren et al., 2000</xref>). Moreover chick retinal axon growth cones collapse in response to somite extracts in vitro (<xref ref-type="bibr" rid="bib79">Vermeren et al., 2000</xref>), and in further confirmation we found that they collapse in response to PDI+GSNO (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1h</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The significance of PDI as an ER-based foldase/isomerase is well known, but the biological role of csPDI is less clear-cut. It has been implicated in processes such as platelet aggregation and thrombosis, and in animal cell infection by a variety of micro-organisms (<xref ref-type="bibr" rid="bib2">Ali Khan and Mutus, 2014</xref>). Here we have identified a key function for csPDI in contact repulsion using a biological system. Consistent with its location at the cell surface, somite csPDI is an O-glycosylated protein, as shown by our lectin-binding studies (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>) and by Bi et al. for human Jurkat T cells (<xref ref-type="bibr" rid="bib8">Bi et al., 2011</xref>). In keeping with this, it has been shown that contact between a single DRG growth cone filopodium and the surface of a P-half-somite cell in vitro is sufficient to initiate a rapid filopodial withdrawal/repulsive response, followed by reorientation of the growth cone away from the cell (<xref ref-type="bibr" rid="bib73">Steketee and Tosney, 1999</xref>). The rapid nature of this response, combined with our finding that somite extract collapse-inducing activity is depleted using the lectins PNA and jacalin (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>), argue strongly that repulsion is likely to arise from the activity of csPDI rather than ER-based PDI. These lectins have specificity for O-glycans that are synthesised and linked to protein in the Golgi apparatus before the glycoprotein is transported to the cell surface. Also consistent with a repulsion mechanism, inhibition of PDI activity in vivo, using either siRNA knockdown or PACMA 31 inhibition of enzyme activity, causes axons to traverse the P-half-somites. Since PDI is a multifunctional enzyme operating both within and outside cells, it is possible that this phenotype might arise for other reasons. However we used the same target for gene knockdown experiments as used by <xref ref-type="bibr" rid="bib87">Zai et al., 1999</xref>., who showed that cell viability is unperturbed despite inhibition of csPDI expression. Additionally we saw no change in somite morphology despite loss of lectin binding at the cell surface.</p><p>In chick somites the onset of csPDI expression in P-half-sclerotome immediately precedes the first emergence of spinal axons in the A-half. This matches well the proposed function of csPDI in mediating contact repulsion of outgrowing motor and sensory axons. The selective migration of neural crest cells in A-half-sclerotomes precedes by several hours the first axon outgrowth at each segmental level in the chick embryo, and is likewise matched temporally by the onset of expression of the secreted repellent Sema3F in newly-formed P-half-sclerotomes (<xref ref-type="bibr" rid="bib27">Gammill et al., 2006</xref>). The secreted axon repellent protein Sema3A is additionally expressed selectively in P-half-sclerotome (<xref ref-type="bibr" rid="bib21">Eickholt et al., 1999</xref>) (see also <xref ref-type="bibr" rid="bib70">Shepherd et al., 1996</xref>). However no long-distance axon repulsion is detected in collagen gel co-explants of DRGs with dissected P-half-sclerotomes (<xref ref-type="bibr" rid="bib42">Keynes et al., 1997</xref>). Moreover, segmented spinal nerve patterning persists in compound Neuropilin1/2 mutant mice in which somite-based Semaphorin signalling is depleted (<xref ref-type="bibr" rid="bib67">Schwarz et al., 2009</xref>; <xref ref-type="bibr" rid="bib37">Huber et al., 2005</xref>), presumably because csPDI expression in these mice compensates disrupted neural crest migration.</p><p>Together these observations imply that the segmental patterning of neural crest cells and axons is regulated predominantly by distinct molecular signals. Supporting this, the Eph-family receptor tyrosine kinase EphB2 and its ligand ephrin-B1 have been additionally implicated in somite-based repulsion of neural crest cells (<xref ref-type="bibr" rid="bib46">Krull et al., 1997</xref>; <xref ref-type="bibr" rid="bib80">Wang and Anderson, 1997</xref>; <xref ref-type="bibr" rid="bib19">Davy and Soriano, 2007</xref>), but shown not to be necessary for motor axon segmentation (<xref ref-type="bibr" rid="bib44">Koblar et al., 2000</xref>). Other candidate axon-repellent molecules that are preferentially expressed in P-half-sclerotome have been identified (<xref ref-type="bibr" rid="bib47">Kuan et al., 2004</xref>) but their in vivo roles have remained uncertain. For T-cadherin (<xref ref-type="bibr" rid="bib59">Ranscht and Bronner-Fraser, 1991</xref>) and F-Spondin (<xref ref-type="bibr" rid="bib78">Tzarfati-Majar et al., 2001</xref>), while each of these proteins has been shown to inhibit motor axon growth in vitro, mouse gene knockout phenotypes consistent with a role in spinal nerve segmentation in vivo have not been published to date (<xref ref-type="bibr" rid="bib14">Ciatto et al., 2010</xref>; <xref ref-type="bibr" rid="bib53">Palmer et al., 2014</xref>). The chondroitin sulphate proteoglycans aggrecan and versican provide further similar examples (<xref ref-type="bibr" rid="bib81">Watanabe and Yamada, 2002</xref>; <xref ref-type="bibr" rid="bib56">Perissinotto et al., 2000</xref>; <xref ref-type="bibr" rid="bib20">Dours-Zimmermann et al., 2009</xref>). Also the extracellular matrix glycoprotein Fibulin 2 was recently found to have P-half-specific expression in a RNA-seq screen of dissected mouse A- and P-half-somites (<xref ref-type="bibr" rid="bib66">Schaeffer et al., 2018</xref>). While Fibulin 2 does not possess intrinsic growth cone collapse-inducing activity, the evidence indicates that it promotes Sema3A signalling in the P-half-sclerotome, and may contribute to spinal nerve fasciculation in vivo (<xref ref-type="bibr" rid="bib66">Schaeffer et al., 2018</xref>). Last, the identification by Pfaff and colleagues of the <italic>Columbus</italic> mouse mutation (<xref ref-type="bibr" rid="bib4">Bai et al., 2011</xref>) provides a striking example of loss of motor/sensory axon repulsion in mouse P-half-somites. Here, the loss of Presenilin-1 (PS-1) function causes outgrowing axons to traverse both halves of the somite. This is explicable by the consequent loss of <italic>Notch</italic> function required to generate P-half-somite polarity, upstream of P-half-somite differentiation, as seen in two previous PS-1 mouse gene knockout studies (<xref ref-type="bibr" rid="bib69">Shen et al., 1997</xref>; <xref ref-type="bibr" rid="bib83">Wong et al., 1997</xref>).</p><p>Regarding the mechanism of csPDI, the models of <xref ref-type="bibr" rid="bib87">Zai et al., 1999</xref> (using human erythroleukaemia cells), <xref ref-type="bibr" rid="bib58">Ramachandran et al., 2001</xref> (using fibroblasts and endothelial cells) and <xref ref-type="bibr" rid="bib71">Sliskovic et al., 2005</xref> have been proposed to explain how NO entry into these cells is regulated by a transnitrosation mechanism facilitated by csPDI. These in vitro cellular models are directly applicable to the axon growth cone/somite system in vivo. We suggest that csPDI acts as a de-nitrosylase, operating constitutively at the P-half-somite cell surface to promote the transfer of NO• from extracellular S-nitrosothiols into the cytosol of contacting growth cone filopodia, thereby initiating repulsion/collapse (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Extracellular S-nitrosoglutathione (GSNO) may provide a ubiquitous source of NO donor, as suggested for csPDI activity in the context of platelet aggregation (<xref ref-type="bibr" rid="bib68">Shah et al., 2007</xref>). Critically we have shown that its ambient extracellular concentration in vivo (~1 µM) is sufficient, in combination with purified PDI, to elicit growth cone collapse in vitro. Alternatively or additionally, other NO donors may be involved.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Schematic diagram of the proposed action of csPDI in mediating growth cone repulsion by NO.</title><p>1. A filopodium (blue) contacts a sclerotome cell in the posterior/P-half-somite, where it encounters csPDI, leading to the denitrosylation of a NO-donor molecule, for example GSNO. This reaction can be blocked by PACMA 31, so preventing collapse. 2. NO (which is known to cross cell membranes) is transferred into the filopodium as a result, where it may additionally regulate nNOS activity (<xref ref-type="bibr" rid="bib6">Benhar et al., 2009</xref>). 3. As shown by <xref ref-type="bibr" rid="bib76">Stroissnigg et al., 2007</xref>., nNOS activation causes nitrosylation of cysteine 2457 in the COOH terminus of the MAP1B light chain LC1. They propose that the resulting conformational change in LC1 enhances MAP1B/microtubule binding, which in turn blocks activity of the anchored motor protein dynein. Dynein normally provides a tubulin/minus-end-directed motor activity via its motor domains (filled green circles) that drives axon extension through interaction with microtubules. This is counteracted by a retraction force due to cortical actin/myosin, so that dynein blockade converts filopodial extension to filopodial retraction/repulsion (large red arrow). MT, microtubule-binding domain of MAP1B/LC1; C, COOH terminus of LC1. The lower part of this diagram is adapted from the scheme of <xref ref-type="bibr" rid="bib76">Stroissnigg et al., 2007</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54612-fig5-v3.tif"/></fig><p>The transnitrosation model is well supported by the finding that DRG/sensory axon growth cones collapse when exposed in vitro to the NO donors 3-morpholino-syndoninime (SIN-1) (<xref ref-type="bibr" rid="bib35">Hess et al., 1993</xref>) and NOC-7 (<xref ref-type="bibr" rid="bib22">Ernst et al., 2000</xref>; <xref ref-type="bibr" rid="bib34">He et al., 2002</xref>). SIN-1-induced collapse is prevented by the presence of haemoglobin, which binds released NO (<xref ref-type="bibr" rid="bib35">Hess et al., 1993</xref>), and we have shown that both myoglobin, which similarly binds released NO, and the membrane-impermeable NO-scavenger PTIO (<xref ref-type="bibr" rid="bib25">Flögel et al., 2001</xref>) deplete the collapse-inducing activity of somite extracts. Moreover nNOS inhibition by L-NAME prevents such collapse, indicating that NO signalling may be further amplified in the growth cone by nNOS activity (<xref ref-type="bibr" rid="bib6">Benhar et al., 2009</xref>).</p><p>How might NO signalling in the growth cone influence the cytoskeleton? Our results accord well with the proposal of <xref ref-type="bibr" rid="bib76">Stroissnigg et al., 2007</xref> that, in axons extending in vitro, growth cone retraction is counteracted by a microtubule/dynein-based system. S-nitrosylation of LC1 induces a conformational change that enhances binding of the LC1-HC complex to microtubules, so blocking dynein action and promoting retraction over extension. Correspondingly, in the somite system in vivo both motor and sensory axon growth cones extending at the A/P-half-somite boundaries will make filopodial contact with P-half-somite cells expressing csPDI, triggering NO-mediated repulsive signalling. Consistent with this, using the iodo-TMT reagent we find that LC1 is the only S-nitrosylated protein detected in cell free extracts of dissected somite strips, which necessarily include growth cone proteins.</p><p>The observation that a repellent activity closely similar to the somite system is expressed in mammalian forebrain grey matter is of particular interest, and extends the range of brain proteins originally identified as developmental axon repellents (<xref ref-type="bibr" rid="bib60">Raper and Kapfhammer, 1990</xref>; <xref ref-type="bibr" rid="bib17">Cox et al., 1990</xref>). Collapse-inducing activity is significantly reduced using the lectins PNA and jacalin (this study and <xref ref-type="bibr" rid="bib41">Keynes et al., 1991</xref>), and is also prevented using a variety of small molecule inhibitors (PACMA 31, rutinoside, GSH) as well as myoglobin and anti-PDI antibody. Our findings additionally implicate the astrocyte as a source of this activity, since human astrocytic (1718) cells and rat cortical primary astrocytes express csPDI, and 1718-cell-derived growth cone collapse activity is removed by immobilized PNA and jacalin. In view of the involvement of NO/S-nitrosylation signalling in the csPDI-mediated repulsion mechanism, rather than a protein-based ligand-receptor interaction, a broad range of CNS axon types may prove susceptible to it. And consistent this, we have shown previously that chick CNS (retinal and telencephalic) axons respond to the somite repellent in vivo (<xref ref-type="bibr" rid="bib41">Keynes et al., 1991</xref>; <xref ref-type="bibr" rid="bib79">Vermeren et al., 2000</xref>). It may also be significant that csPDI expression by human malignant glioblastoma cells has been related to their invasiveness within the brain (<xref ref-type="bibr" rid="bib31">Goplen et al., 2006</xref>).</p><p>The neuron may be another source of brain-derived csPDI, since a recent proteomic analysis of CNS synaptic cleft proteins identified csPDI/P4HB among the most enriched candidates at both excitatory and inhibitory synapses in embryonic rat cortical neuronal cultures <xref ref-type="bibr" rid="bib48">Loh et al., 2016</xref>; csPDI has also been identified at the surface of both neuroblastoma cells (<xref ref-type="bibr" rid="bib85">Xiao et al., 1999</xref>) and retinal cells (<xref ref-type="bibr" rid="bib55">Pariser et al., 2000</xref>). Together with the experiments reported in this study, these findings collectively raise the possibility that csPDI is 'bifunctional' in promoting both adhesive and repulsive neuronal/glial interactions in the CNS. For example, NO signalling is implicated in synapse elimination during CNS development (<xref ref-type="bibr" rid="bib84">Wu et al., 1994</xref>; <xref ref-type="bibr" rid="bib29">Gibbs and Truman, 1998</xref>), and csPDI activity might provide an extracellular source of NO alongside intracellular nNOS activity.</p><p>In sum, this study reveals a novel role for the multifunctional enzyme PDI in the periodic patterning of peripheral spinal nerves, ensuring their separation in somites from developing cartilage and bone. The additional expression of csPDI at the astrocyte surface, and its function in promoting NO-based repulsion of growing nerve terminals, suggest a promising candidate for regulating axon growth and plasticity that may be widely distributed in the developing and mature nervous system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Cell line (<italic>Homo-sapiens</italic>)</td><td valign="top">Human astrocytoma- <break/>derived 1718 cells</td><td valign="top">ATCC</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_1118">CVCL_1118</ext-link></td><td valign="top">authentication by STR profiling mycoplasma contamination not tested (used directly from ATCC)</td></tr><tr><td valign="top">Transfected construct (<italic>Gallus gallus</italic>)</td><td valign="top">siRNA to 3'UTR of chick P4HB/PDIA1</td><td valign="top">This paper</td><td valign="top">siRNA</td><td valign="top"><named-content content-type="sequence">TCGCCCTCACTTGTCTTTA</named-content></td></tr><tr><td valign="top">Transfected construct (<italic>Gallus gallus</italic>)</td><td valign="top">scrambled siRNA</td><td valign="top">This paper</td><td valign="top">siRNA</td><td valign="top"><named-content content-type="sequence">GCTCTCTCGTCTATCTACT</named-content></td></tr><tr><td>Biological sample (<italic>Gallus gallus</italic>)</td><td>somite extract</td><td>This paper</td><td/><td>Freshly isolated from Gallus gallus</td></tr><tr><td>Biological sample (<italic>Rattus norvegicus domestica</italic>)</td><td>rat forebrain extract</td><td>This paper</td><td/><td>Freshly isolated from Rattus norvegicus <break/>domestica</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse IgG2a anti-tubulin β3 <break/>(mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">clone TUJ1 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2315519">AB_2315519</ext-link></td><td valign="top">(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-PDI (rabbit polyclonal)</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# P7496</td><td valign="top">(1:250 live staining) <break/>(1:500 post-fixation staining) <break/>(1:20,000 western blot)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-calnexin mouse IgG2b <break/>(mouse monoclonal)</td><td valign="top">Abcam</td><td valign="top">clone 6F12BE10 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10860712">AB_10860712</ext-link></td><td valign="top">(1:100 live staining) <break/>(1:200 post-fixation staining)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 488 Goat anti-Mouse IgG1 <break/>(goat polyclonal)</td><td valign="top">Invitrogen</td><td valign="top">A-21121 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535764">AB_2535764</ext-link></td><td valign="top">1:500</td></tr><tr><td valign="top">Antibody</td><td valign="top">Alexa Fluor 594 Goat anti-Mouse IgG2a (goat polyclonal)</td><td valign="top">Invitrogen</td><td valign="top">A-21135</td><td valign="top">1:500</td></tr><tr><td valign="top">Antibody</td><td valign="top">Peroxidase-conjugated Goat <break/>anti-mouse IgG <break/>(goat polyclonal)</td><td valign="top">Jackson Immuno <break/>Research</td><td valign="top">115-035-003</td><td valign="top">1:500</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">plasmid encoding human PDIA1 (18–508)</td><td valign="top">Addgene</td><td valign="top">hPDI1_18–508_WT_pFLAG-CMV1 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_31382">Addgene_31382</ext-link></td><td valign="top">Depositing lab: <break/>Prof David Ron <break/>University of Cambridge, UK</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Uncx4.1</italic></td><td valign="top">This paper</td><td valign="top">primer synthesis</td><td valign="top">(forward) <named-content content-type="sequence">ATCGATGGATTACTGAGCGG</named-content> <break/>(reverse) <named-content content-type="sequence">TAATACGACTCACTATAGGGAGGTTTAAGCAAACGGACGCTG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>Tbx18</italic></td><td valign="top">This paper</td><td valign="top">primer synthesis</td><td valign="top">(forward) <named-content content-type="sequence">GTAATGCTGACTCCCCGGTA</named-content> <break/>(reverse) <named-content content-type="sequence">TAATACGACTCACTATAGGGAGACTGGTTTGGTTTGTGAGCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">T7 promoter</td><td valign="top">Sigma-Aldrich</td><td valign="top">primer synthesis</td><td valign="top"><named-content content-type="sequence">TAATACGACTCACTATAGGGAG</named-content></td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">In-Fusion HD Cloning</td><td valign="top">Clontech</td><td valign="top">639647</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">ER-TrackerGreen <break/>FL Glibenclamide</td><td valign="top">Thermo Fisher</td><td valign="top">E34251</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Chick embryo grafting procedure</title><p>Fertilized hens’ eggs (Gallus gallus, Bovans Brown variety; Winter Egg Farms, Fowlmere, Cambridgeshire) were incubated at 38°C to obtain embryos at stage 12–14 (<xref ref-type="bibr" rid="bib32">Hamburger and Hamilton, 1951</xref>) (16–22 somites). Eggs were windowed and 0.2–0.5 mL of a 1:10 mixture of India ink (Fount India, Pelikan) and phosphate-buffered saline (PBS) was injected into the sub-blastodermal space. The window was lined with silicone grease, and the embryo raised to the level of the shell by pipetting PBS into the egg through the window, creating a bubble of PBS held in place by the grease. An incision was made between the neural tube and newly-formed sclerotome on one side of the embryo, and a single Affi-Gel Blue agarose gel bead (BioRad, Cibacron blue coupled to agarose, 30–50 μm diameter) impregnated with PACMA31 or PACMA56 (500 μM in PBS) was implanted into the resulting space (adjacent to the neural tube medially and notochord ventrally). Embryos were then re-incubated for 24–36 hr before fixing and processing for axon staining (see below) as whole-mounts or as (left and right) half-embryo-mounts. PACMA31 or PACMA56 solution was made by adding 0.5 ml dimethylsulfoxide to 2.2 mg PACMA to make a 10 mM stock solution. This was diluted x20 in PBS to make a 500 μM working solution, in which the Affigel beads were then placed for 2–3 hr at 21°C prior to implantation.</p></sec><sec id="s4-2"><title>Preparation of tissue extracts</title><p>Stage 16–18 chick embryo trunks (comprising ectoderm, somites with DRG neurons, and motor axons, neural tube and notochord) or somite strips (ectoderm, somites with DRG neurons and motor axons) were dissected and immediately placed on solid CO<sub>2</sub> and transferred to −80°C for longer storage. Trunks from ~60 embryos were homogenised in 1 ml solubilisation medium [2% w/v CHAPS in PBS made 1 mM with sodium orthovanadate and 1 tablet cØmplete protease inhibitor cocktail (Roche) per 50 ml of solution] on wet ice by shearing through a 20G then 26G needle. Further homogenisation was carried out with grinding resin (GE Healthcare) and electrically-driven disposable pestles (GE Healthcare). Following centrifugation at 14,000 g for 5 min at 4°C to remove the grinding resin, the supernatant fluid was centrifuged at 100,000 g for 1 hr at 4°C in a Beckman Optima TL ultracentrifuge using a TLS-55 rotor. Supernatant fluid was incorporated into liposomes as described by <xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>. Pellets of 1718 cells were similarly extracted. Dissected rat (typically 3 months old) forebrain grey matter was stored at −80°C and allowed to thaw on wet ice in the above solubilisation medium, ratio 0.5 g wet weight tissue to 2 ml medium. Following homogenisation in a Dounce Tissue Grinder (loose and tight fitting glass pestles were used in succession) and centrifugation at 14,000 g for 5 min at 4°C, the supernatant fluid was centrifuged at 100,000 g for 1 hr at 4°C as described above. The clear supernatant fluid [14.9 ± 0.5 μg protein/μl (s.e.m.)] from the latter centrifugation was used for incorporation into liposomes.</p></sec><sec id="s4-3"><title>Growth cone collapse assays</title><p>These were carried out using whole- or half-DRGs dissected from embryonic day 7 (E7) chick embryos (stage 30–32) or (for retinal axons) from dissected pieces (~50 μM diameter) of E7 chick retina. DRG explants were grown for 24 hr on glass coverslips coated with poly-L-lysine (Sigma-Aldrich) and laminin (Sigma-Aldrich), in the presence of nerve growth factor (NGF, 40 ng/ml, Sigma-Aldrich); full details of the assay method used in our laboratory have been published (<xref ref-type="bibr" rid="bib15">Cook et al., 2014</xref>). Retinal explants were grown as for DRGs but without NGF and with medium supplemented with N-2 (Sigma-Aldrich, 100x concentrate) and bovine pituitary extract (200 μg/ml, Life Technologies). Cultures were fixed 1 hr after addition of each treatment, and growth cones were assessed by phase-contrast microscopy, observer-blind to treatment condition. Between 50 and &gt;100 growth cones were assayed in each DRG culture. They were classified as spread or collapsed according to published morphological criteria (growth cones with two or fewer filopodia were scored as collapsed, see <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b</xref>; <xref ref-type="bibr" rid="bib15">Cook et al., 2014</xref>). We have previously shown the validity of this method using phase contrast-microscopy when compared to equivalent results using phalloidin staining (<xref ref-type="bibr" rid="bib49">Manns et al., 2012</xref>). Results are presented as the mean percentage collapse of growth cones extended from individual DRG explants.</p></sec><sec id="s4-4"><title>Assessment of PDI inhibitors using collapse assay</title><p>Conditions of controls and reagents were assigned randomly to each culture and all experiments were blind-coded. Unless otherwise specified all components were added simultaneously and incubated for 1 hr (37°C/5% CO<sub>2</sub>) before fixation. In experiments with antibody preparations, controls using the same concentration of non-immune rabbit IgG (Sigma-Aldrich G2018, Lot#051K7670), BSA and sodium azide were included. Immunodepletion experiments were performed using Magnetic Dyna Protein A beads (Invitrogen, 70 μl packed beads) washed twice in 0.1M phosphate buffer (pH 8) with 0.01% Tween 20 (1ml) by end-over-end mixing for 2.5 hr at 4°C. Washed beads were added to rat forebrain extracts (RFE) containing either anti-PDI (Sigma-Aldrich P7496 Lot#054K4801), non-immune rabbit IgG or bovine serum albumin (BSA) and mixed end-over-end for 1 hr at 4°C. Beads were removed on a magnetic separator and the extract subjected to a repeated extraction with fresh beads. Treated extracts were incorporated into liposomes.</p></sec><sec id="s4-5"><title>Live-staining of csPDI in whole-mounted somite-strips</title><p>Stage 22–24 chick embryos were removed from the egg and washed in Leibovitz's L-15 medium (Thermo Fisher Scientific) supplemented with 1% L-Glutamine-Penicillin-Streptomycin solution (Sigma-Aldrich). Embryos were pinned out along the A-P axis, ventral-up, in a Sylgard (Dow Corning) coated dish containing medium. After removal of the endoderm, embryos were re-pinned dorsal-up and the neural tube, intermediate mesoderm and lateral plate mesoderm were separated from the paraxial/somite mesoderm. Strips of somite mesoderm were dissected and collected in 4-chambered cell culture slides (BD Falcon) containing L-15 medium and sheep serum (Sigma-Aldrich, 10% v/v) as blocking solution, and slides incubated for 15 min. Primary anti-PDI antibody (Sigma-Aldrich P7496) or rhodamine-conjugated PNA (Vector labs) was added (1:500 v/v) to 3 chambers per slide and incubated for 1 hr at 38°C. Strips were fixed with 4% formaldehyde for 30 min, washed x3 with PBS, 5 min per wash, then incubated with secondary antibody (anti-rabbit IgG, Invitrogen) for 2 hr at 21°C. Controls for anti-PDI binding, each in the 4th chamber per slide, were: absence of primary antibody, primary antibody pre-absorbed with purified bovine PDI (Sigma-Aldrich, P3818, concentration 5x molarity of anti-PDI antibody), and rabbit IgG (1:500). Slides were mounted with Fluoromount G (SouthernBiotech) and viewed using a Zeiss Axioskop fluorescence microscope. Each staining procedure was repeated at least x3.</p></sec><sec id="s4-6"><title>Sclerotome and retinal cell staining and transfection</title><p>Dissected somite strips were collected in a 2 ml LoBind tube (Eppendorf) containing L15 medium, and sclerotome cells were dissociated with a 25G needle, after which 20 μl of cells were transferred into each chamber of a 4-chambered cell culture slide (BD Falcon) containing 490 μl medium per chamber pre-warmed at 37°C. To maintain sclerotome differentiation a notochord fragment was added to each well. Slides were cultured in a humidified box at 37°C for 16 hr, after which csPDI was assessed by anti-PDI- and PNA-staining as described above for somite strips. For retinal cells, eyes were removed from stage 22–24 embryos using a microscalpel, and retinal cells dissociated and stained as for sclerotome cells. For siRNA transfection, cells were incubated at 38°C for 16 hr. 10 μl of transfection mix [12.5 μg siRNA in 100 μl 5% glucose and 1.5 μl TurbofectTM (Thermo Fisher Scientific)] in 490 μl of DMEM (Sigma-Aldrich) supplemented with B-27 (Life Technologies) and NGF (Sigma-Aldrich) was then added to cultures. After overnight incubation at 38 °C cells were washed x3 in DMEM and incubated for 3 hr with B-27/NGF-supplemented DMEM.</p></sec><sec id="s4-7"><title>Human astrocytic (1718) cell staining</title><p>Human astrocytoma-derived 1718 cells [CCF-STTG1 (ATCC CRL-1718TM)] were cultured in RPMI 1640 medium (ATCC modification, Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco) and penicillin-streptomycin (Gibco). Cells were maintained at 37°C in 5% CO<sub>2</sub>. At each passage, cells were detached using Trypsin-EDTA (0.05%, Gibco), centrifuged at 1000 g for 5 min and plated in cell culture flasks (Nunc). After removing culture medium, cells were scraped in PBS or diethyl pyrocarbonate (DEPC) PBS and collected in an Eppendorf tube, then centrifuged at 2,000 g for 10 min at 4°C. Re-suspended cells were washed once with RPMI 1640 and blocked with RPMI 1640/10% goat serum (Sigma-Aldrich) for 10 min at room temperature. They were plated in 4-well Millicell EZ slides (Millipore) coated with poly-L-lysine (0.01%, Sigma-Aldrich), at a concentration of 50,000 cells per well (1.7cm2). Cells were incubated with primary antibody in RPMI 1640/1% goat serum for 30 min at 4°C, washed x3 with RPMI 1640, then incubated with secondary antibody in RPMI 1640/1% goat serum for 1 hr at 4°C and washed x3 with RPMI. Cells were fixed with 4% w/v formaldehyde and 15% w/v sucrose in PBS, pH 7.4, for 10 min at 21°C, then washed for 5 min x3 with PBS. For live-cell imaging of the ER, cells were washed once with HBSS and incubated with ER-TrackerTM Green (BODIPY FL Glibenclamide, Life Technologies) for 20 min at 37°C. Cells were then washed x3 with HBSS and slides were mounted using Fluoromount-G (Southern Biotech). For intracellular immunostaining cells were washed x1 with PBS, fixed with 4% w/v formaldehyde/15% w/v sucrose in PBS for 10 min at 21°C, then washed for 5 min x3 with PBS. Cells were blocked with PBS with or without 0.1% Triton X-100 (PBS-T) and 10% v/v goat serum for 1 hr at 21°C. They were then incubated in primary antibody in PBS-T/1% goat serum overnight at 4°C, washed x3 with PBS, incubated for 1 hr in secondary antibody in PBS-T at room temperature, then washed x3 with PBS. Nuclear staining was performed with 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) diluted 1:4000 in PBS, or with Hoechst diluted 1:5000 in PBS. Primary antibodies were: rabbit anti-PDI (IgG polyclonal, Sigma-Aldrich) used at 1:250 (live-staining) or 1:500 (post-fixation staining); anti-calnexin (Abcam, clone 6F12BE10, mouse IgG2b) used at 1:100X (live-staining) and 1:200 (post-fixation staining). Secondary antibodies were goat anti-rabbit IgG and goat anti-mouse IgG (Alexa Fluor 594) used at 1:500.</p></sec><sec id="s4-8"><title>Embryo fixation and dehydration</title><p>Stage 19–22 embryos were washed x2 in PBS before removing the extra-embryonic tissues. Embryos were fixed in 4% w/v formaldehyde for 2 hr at 21°C, or overnight at 4°C, then rinsed in PBS on a mechanical shaker for 5 min and dehydrated through a series of 10 min washes x1 with 25, 50, 75% v/v methanol/PBS and 100% methanol. After one further 30 min wash in 100% methanol, embryos were stored in methanol at −20°C until required.</p></sec><sec id="s4-9"><title>Axon staining</title><p>After rehydration into PBS-T, embryos were blocked in PBS-T/10% goat serum for 3 hr at 21°C, then incubated in fluorescein-conjugated PNA (Vector Labs) for sclerotome csPDI, or in anti-tubulin βIII (clone TUJ1, Mouse IgG2a, BioLegend) for axon staining, both at 1:500 in PBS-T/10% v/v goat serum for 12–18 hr at 4°C. Embryos were then washed x4 for 20 min with PBS-T. Secondary antibody (peroxidase goat anti-mouse IgG, Jackson ImmunoResearch) was used at 1:500 in PBS-T/10% goat serum for 2 hr at 21°C, followed by 20 min washes x4 in PBS-T. Embryos were then incubated with 500 μg/ml diaminobenzidine (DAB) substrate and 0.006% H<sub>2</sub>O<sub>2</sub> in PBS/0.5% Triton, and the colour reaction was developed for 5–10 min at 21°C.</p></sec><sec id="s4-10"><title>Vibratome sectioning</title><p>Formaldehyde-fixed embryos were embedded in 10% gelatin (bloom 300, Sigma-Aldrich) in PBS at 38°C for 30 min. Cryomolds (Tissue-Tek) with gelatin were set at 21°C for 15 min, after which embryos were transferred to them and the gelatin flattened and set at 4°C for 30 min. Blocks were cut and fixed with 4% formaldehyde at 4°C for at least 72 hr, then washed for 10 min x3 in PBS, trimmed and mounted in a Leica VT1000 S vibratome. Sections were cut at 70 µM using a steel blade and mounted on glass slides (VWR International) using Fluoromount G.</p></sec><sec id="s4-11"><title>Primary cultures of rat cortical astrocytes</title><p>Cortical hemispheres from neonatal rat pups (P1-P3) were isolated and dissected in ice-cold DMEM containing penicillin-streptomycin (Gibco). Care was taken to remove meninges and white matter. Cortices from up to 12 pups were pooled and sub-divided in a Petri dish using a razor blade. The tissue was transferred to a 15 ml Falcon tube and spun briefly, then resuspended in 2 ml papain solution [0.75% v/v of papain (25 mg/ml, 17 U/mg protein, Sigma-Aldrich), 40 μg/ml DNase I type IV, 2 mM L-Cysteine in DMEM with penicillin-streptomycin] and incubated for 1 hr at 37°C with occasional resuspension. The enzymatic digestion was quenched by adding 2 ml trypsin-inhibitor solution [500 ug/ml BSA, 40 μg/ml DNase I type IV, 1 mg/ml Trypsin inhibitor (Sigma-Aldrich)]. Cells were then dissociated by mechanical resuspension in 1 ml ovomucoid solution and collected by centrifugation in a 10 ml trypsin-inhibitor solution. They were resuspended in culture medium and plated in poly-D-lysine-coated flasks (cells from 1 to 1.5 brains in one 75 cm<sup>2</sup> culture flask). Cells were cultured at 37°C/5% CO2 in DMEM (Gibco) supplemented with 10% FBS (Gibco) and penicillin-streptomycin. After 7-10d culture cells were shaken in an orbital shaker at 350–400 rpm (1.9 cm orbital radius, MaxQ 4450, ThermoFisher Scientific) at 37°C to obtain a culture of cortical astrocytes. Microglia, neurons and oligodendrocytes were detached after an overnight shaking, and medium was then replaced. Cultures consisted in &gt;90% GFAP-positive cells.</p></sec><sec id="s4-12"><title>siRNA knockdown of csPDI</title><p>The fluorescein-labelled siRNA used to knock down csPDI in the chick embryo was designed according to the sequence of an antisense phosphorothioate (S-oligo; nuclease-resistant oligonucleotide) successfully used by <xref ref-type="bibr" rid="bib87">Zai et al., 1999</xref> to knock down csPDI/PDIA1/P4HB in a human erythroleukemia (HEL) cell line. These authors designed three antisense S-oligos against human PDIA1/P4HB mRNA, and one of these reduced the cell surface expression of P4HB significantly (by 74 ± 9.2% compared to the scrambled S-oligo control). The sequence for the successful oligo was 5′-<named-content content-type="sequence">GCAGCGAGACTCCGAACACGGTA</named-content>-3′, found in the 3’ UTR of the human PDIA1/P4HB mRNA. This sequence was used to find an appropriate target sequence in the 3’ UTR of chicken PDIA1/P4HB (see Key Resources Table), and was selected using BLAST NCBI anSfold (Wadsworth Center) to ensure maximum binding. A FITC-labelled control scrambled siRNA was designed using InvivoGen siRNA Wizard software <ext-link ext-link-type="uri" xlink:href="http://www.sirnawizard.com/scrambled.php">http://www.sirnawizard.com/scrambled.php</ext-link> (see Key Resources Table). All sequences were subjected to NCBI BLAST to ensure gene-specificity and to avoid mis-targeting. Rescue experiments used a plasmid encoding a fusion protein of mature human PDIA1 (18–508), tagged at its N-terminus with a bovine pre-pro-trypsinogen signal peptide (bPPTSP) and a FLAG-M1 epitope that is exposed after cleavage of the signal peptide (kind gift of Prof David Ron, Department of Clinical Biochemistry, University of Cambridge) (<xref ref-type="bibr" rid="bib88">Zito et al., 2010</xref>).</p></sec><sec id="s4-13"><title>Primer design</title><p>Transcript sequences for selected genes were obtained via the National Center for Biotechnology Information (NCBI) GenBank and Ensembl. Primer pairs for each transcript were designed using the Primer-Blast tool available from the NCBI (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/">http://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link>). Primers were selected according to the following rules: (i) primer length 17–30 base pairs; (ii) CG content 50–60%; (iii) melting temperature 55–80°C; (iv) resulting amplification product 400–1200 base pairs. All potential primers were checked against the G. gallus (taxid:9031) genomic database using the Basic Local Alignment Search Tool (BLAST) from NCBI. The outputs from this last step were used to exclude all primers giving more than one significant region of identity (80% cut-off) against the whole chicken genome, or sharing more than 70% similarity with other genes. Selected primers were synthesized (Sigma-Aldrich) with the T7 promoter primer sequence (<named-content content-type="sequence">TAATACGACTCACTATAGGGAG</named-content>) appended to the 5’ end of the reverse primer, to allow direct generation of digoxigenin-labelled antisense RNA probe by in vitro transcription using T7 RNA polymerase.</p><p>Polymerase chain reaction (PCR) to prepare template for riboprobe synthesis cDNA samples (2 µl) were pipetted into a 200 µl thin-wall centrifuge tube and 36 µl of DEPC-treated water, 6 µl of primer and 50 µl of Reddy Mix PCR Master Mix (AB Gene) was added to each. The contents of the tube were briefly mixed and spun down. Tubes were then placed on a heating block of a hot-lid thermal cycler pre-heated to 95°C. Cycling commenced with an initial 2 min denaturation step at 95°C followed by 34 cycles of 95°C for 25 s, annealing at 50°C for 45 s and elongation at 72°C for 1 min; cycling finished with an extension step of 72°C for 5 min. The PCR product length was checked by agarose gel electrophoresis, and the products stored at −20°C until needed for riboprobe synthesis.</p></sec><sec id="s4-14"><title>Riboprobe synthesis</title><p>20 µl in vitro transcription reactions were prepared by adding to a 200 µl thin-wall PCR tube in the following order: 9 µl DEPC-treated water, 4 µl nucleoside triphosphate (NTP) mix (2.5 mM ATP, 2.5 mM CTP, 2.5 mM GTP, 1.67 mM UTP, 0.833 mM digoxigenin-11-UTP), 2 µl T7 transcription buffer (Ambion), 2 µl T7 RNA polymerase, 1 µl RNase inhibitor (Invitrogen), and 2 µl PCR product. The tube contents were mixed by pipetting and briefly spun in a microfuge (≤1000 g) to settle them. The tube was further incubated at 37°C in a thermal cycler for 2 hr, after which 1 µl DNase I was added and the tube further incubated in a thermal cycler for 15 min at 37°C. To stop the reaction, 1 µl of 0.5M EDTA was added and mixed by pipetting, and the tube contents spun down. The probe was then analysed using a Picodrop spectrophotometer.</p></sec><sec id="s4-15"><title>Isolation of RNA for antisense RNA probes and cDNA synthesis</title><p>Embryos were rinsed with cold diethyl pyrocarbonate (DEPC)-PBS and transferred to a methanol-washed Petri dish coated with Sylgard. The extra-embryonic membranes were removed using Watchmaker's forceps pre-cleaned with RNAse Zap (Ambion). Embryos were placed in RNAlater (Ambion) and stored overnight at 4°C. Total RNA was extracted using silica-membrane RNeasy spin columns (Qiagen) according to manufacturer’s instructions. cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad) according to manufacturer's instructions and stored at −20°C.</p></sec><sec id="s4-16"><title>Whole-mount in situ hybridization (WMISH)</title><p>Our procedure was based on <xref ref-type="bibr" rid="bib82">Wilkinson, 1998</xref>. Embryos were rehydrated into PBS-T through a series of 75% v/v methanol/ultra-pure water, 50% v/v methanol/ultra-pure water, 25% v/v methanol/PBST. Embryos were transferred into 18-well plates (Nunc). Unless otherwise specified, all reagents were diluted in PBS-T and washes were for 10 min in PBS-T on a rocking platform at 21°C. To increase probe permeability embryos were incubated at 21°C in 10 µg/ml proteinase K (Roche) for the following durations: embryos to stage 15 for 5 min, stage 16–18 for 10 min and stage 19–24 for 15 min. Embryos were rinsed x1, post-fixed for 20 min in 4% formaldehyde and washed x2 to remove fixative. They were equilibrated with hybridization mix [50% v/v formamide, 5X SSC (Sigma-Aldrich), 2% blocking powder (Boehringer, 1096176), 0.1% Triton X-100, 0.1% CHAPS (Sigma-Aldrich), 1 mg/ml tRNA (Sigma-Aldrich), 5 mM EDTA, 50 µg/ml heparin] by rinsing x1 in a 1:1 mixture of PBST/hybridization mix and then x2 in hybridization mix. Plates were then placed at 67°C in a hybridization rocking oven for a minimum pre-hybridization of 2 hr to 12 hr maximum, after which the solution was changed to pre-warmed hybridization solution containing 1 µg/ml RNA probe, and incubated for at least 12 hr to 72 hr maximum. In order to avoid cross contamination, WMISH probes were well separated when the hybridization was being done; vials were leak-proof, and each probe was used no more than x3. After incubation embryos were rinsed x2 and washed x1 with pre-warmed hybridization mix, washed x2 for 30 min with hybridization mix, and then x2 with a 1:1 mixture of hybridization mix/PBS-T at 60°C. Embryos were then rinsed x3 with PBS-T. Hybridization solution was eliminated by 30 min washes x7 in PBST at 21°C in a rocking shaker. To block non-specific binding, embryos were incubated for 1–3 hr in blocking solution (10% v/v Sigma-Aldrich sheep serum in PBS-T) at 21°C. This was replaced with blocking solution containing alkaline phosphatase-conjugated anti-digoxigenin Fab fragments (Roche) at 1:2000 dilution, and embryos were incubated further for 12–18 hr at 4°C. The antibody was removed by rinsing the embryos x3 in PBST with 1 mM levamisol, followed by 4 hr of washes with buffer changes every 30 min; in some cases embryos were left overnight at 4°C. Alkaline phosphatase was detected using a mixture of 4-nitro blue tetrazolium chloride (NBT) and 5-bromo-4-chloro-3'-indolyphosphate (BCIP). Embryos were first washed x2 in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 9.5, 50 mM MgCl2, 0.1% Triton X-100), followed by addition of the reaction mixture (4.5 µl/ml NBT and 3.5 µl/ml BCIP in NTMT). Reactions were left in the dark until a deep purple colour had developed; this could take 3 hr to 5d, and in the latter case the stain solution was replaced daily. Embryos were then washed x3 in PBS-T and fixed in 4% w/v formaldehyde for 12–18 hr at 4°C. The fixative was removed by several PBS washes. Embryos were imaged using a Leica dissecting microscope and prepared for vibratome sectioning.</p></sec><sec id="s4-17"><title>siRNA preparation</title><p>Lyophilized FITC-labelled RNA duplexes (Dharmacon Thermo Scientific) were obtained in 2’ deprotected, annealed and desalted form, dissolved in PCR grade water (Roche) at 3 µg/µl and stored in aliquots at −80°C. The transfection solution was 1 µg/µl siRNA, 10% polyethylene glycol (PEG) (Carbowax 6000, Union Carbide) and 20% TurbofectTM (Thermo Fisher Scientific, Catalog # R0541). For 2.8 µl of siRNA preparation, 1 µl of siRNA, 1.2 µl of 20% PEG stock and 0.6 µl of TurbofectTM were incubated at 21°C for 30 min before application. This technique was also tested using pCAβ-EGFPm5-mU6 (<xref ref-type="bibr" rid="bib11">Bron et al., 2007</xref>), a kind gift of Dr. Matthieu Vermeren (Department of Physiology, Development and Neuroscience, University of Cambridge, UK). The final transfection solution contained 2 µg/µl plasmid, 10% PEG and 40% TurbofectTM. For a final 5 µl of solution, 1 µl of plasmid, 2 µl of 20% PEG stock and 2 µl of TurbofectTM were used; this solution was only used once. For siRNA delivery in ovo, borosilicate glass capillaries (WPI, outside diameter 1.5 mm, inside diameter 1.12 mm) were pulled on a Narishige Puller PC-10 at 62°C. Tips were broken to obtain a suitably narrow internal diameter and capillaries attached to a rubber tube/mouth-pipette.</p></sec><sec id="s4-18"><title>In ovo transfection</title><p>Eggs were cleaned with methanol and 3–4 ml of ovalbumin removed using a 19G needle and syringe. The upper side of the egg was reinforced with adhesive tape and a window ~1 cm diameter cut through shell and tape using curved scissors. The embryo was raised to the level of the window by re-pipetting the ovalbumin, and visualized by injection into the yolk of ~0.2 ml black ink (Pelikan Fount India, 5% in PBS). A small incision was made in the vitelline membrane overlying the posterior part of the embryo using a microscalpel. The glass capillary containing siRNA/plasmid transfection solution was inserted into the most posterior and newly formed somite of stage 10–14 embryos, and carefully advanced anteriorly within or immediately ventral to the somite mesoderm on one side of the embryo, parallel to the neural tube and dorsal to the endoderm, until the most anterior accessible somite was reached. The capillary was then slowly withdrawn and siRNA was injected into 8–12 successive sclerotomes, each over 5–10 s (~0.05 µl total volume injected per embryo). Care was taken to avoid the upper two cervical segments where the avian spinal accessory nerve exits and ascends immediately adjacent to the neural tube. After pipette withdrawal the embryo was returned to the egg by removing 5 ml of ovalbumin, and the window closed with adhesive tape. Each egg was re-incubated for 24 hr, when siRNA delivery in somites on the injected side was confirmed by the presence of fluorescence in &gt;8 consecutive somites in ovo viewed by epifluorescence microscopy. Eggs were then incubated for 24 hr further to stages 22–24, when embryos were processed for somite strip or sclerotome cell culture and staining, or immunohistochemistry or in situ hybridization, all as described above.</p></sec><sec id="s4-19"><title>Antibodies</title><p>Polyclonal rabbit anti-PDI (Sigma-Aldrich P7496) was prepared using PDI purified from bovine liver as immunogen. The whole serum was fractionated and further purified by ion-exchange chromatography to provide the IgG fraction essentially free of other rabbit serum proteins. In this study Lot#054K4801 (protein content 7.1 mg/ml in 0.1M phosphate buffered saline pH 7.4 containing 15 mM sodium azide) was used. Polyclonal anti-PDI antibody Abcam ab31811 (0.4 mg/ml PDI Ab, 1% BSA, 2% Sodium Azide) was raised in rabbit against a synthetic peptide corresponding to human PDI amino acids 400–500 conjugated to keyhole limpet haemocyanin and immunogen affinity-purified; this contained IgG at 0.4 mg/ml in 1% BSA, and PBS pH 7.4 containing 0.02% sodium azide as preservative.</p></sec><sec id="s4-20"><title>PDI inhibitors</title><p>Bacitracin (Fluka Lot#13Z3372) was examined for protease activity using azocasein (Sigma-Aldrich Lot#039K7002) as a substrate and protease from Bacillis liceniformis (Sigma-Aldrich Lot#040M1970V) as a standard (<xref ref-type="bibr" rid="bib64">Rogelj et al., 2000</xref>). A trace (&lt;0.05%) of enzyme was detected and enzyme-free bacitracin reagent was prepared by gel filtration through Sephadex G100 (<xref ref-type="bibr" rid="bib64">Rogelj et al., 2000</xref>). 16F16 (Lot#051M4613V), phenylarsine oxide (Lot#056K1654) and Rutin hydrate (quercetin-3-rutinoside:≥94%[HPLC] Lot#BCBH6323V) were purchased from Sigma-Aldrich. T3 (3,3’,5’ triiodo-L-thyonine: Sigma-Aldrich ≥ 95%[HPLC] Lot#016K1628V) was acetylated with acetic acid N-hydroxysuccinimide ester (Apollo Scientific) as described (<xref ref-type="bibr" rid="bib26">Gallina et al., 2002</xref>) and the product shown to be homogeneous by thin layer chromatography. The propynoic acid carbamoyl methyl amines PACMA31 and PACMA56 were synthesised as described (<xref ref-type="bibr" rid="bib86">Xu et al., 2012</xref>).</p></sec><sec id="s4-21"><title>Other reagents</title><p>S-Nitrosoglutathione (Lot#055M403V), L-glutathione reduced (G4251 Lot#SLBH7927V), L-glutathione oxidised (G4626 Lot#100K727625), DL-dithiothreitol (43819, Lot#BCBG3415V) and eosin 5-isothiocyanate (Lot#BCBK9368V) were obtained from Sigma-Aldrich, and L-homocysteine (Lot#B1612) from Santa Cruz Biotechnology. Sema 3A/Fc chimera was from R and D Systems (Lot#1250–53). Agarose bound Peanut Agglutinin (Lot#ZA0611; binding capacity &gt;4.5 mg asialofetuin/ml of gel) and Agarose bound Jacalin (Lot#ZA1021) were from Vector Laboratories. Cyanogen bromide-activated Sepharose 4B beads (Sigma C9142) were used to couple purified bovine serum albumin (BSA). After coupling the gel was blocked with 1 mM ethanolamine. Beads used in these experiments contained 9.48 mg BSA per ml of settled gel.</p></sec><sec id="s4-22"><title>Protein assay</title><p>Protein assays were performed with bicinchoninic acid reagent [Pierce BCA protein assay kit (Lot#QA214075); Sigma Bicinchoninic acid solution (Lot#SHBH4613V) and copper(II) sulphate (Lot#SLBJ6167V) with bovine serum albumin (Pierce Lot#BB42996, 2.0 mg/ml in 0.9% NaCl)] as standard, and using the enhanced protocol (60°C for 30 min). A separate standard curve was constructed for each assay and the sample was subject to at least 3 separate dilutions which were each determined in duplicate.</p></sec><sec id="s4-23"><title>Purification of csPDI from somites</title><p>A total of 400 chick embryo trunks were fractionated by affinity chromatography on agarose-bound-PNA (Vector Labs), following procedures used previously in the laboratory (<xref ref-type="bibr" rid="bib18">Davies et al., 1990</xref>). Care was taken to elute the affinity column with 0.5M NaCl 1% CHAPS (w/v) and 100 mM Tris-HCl (pH7.5), followed by elution with 0.4M lactose/2% CHAPS (w/v) in PBS. Eluates (20 μL) were concentrated using StrataClean Resin (Agilent Technologies) (<xref ref-type="bibr" rid="bib10">Bonn et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Otto et al., 2017</xref>). Protein bound to the resin was eluted using SDS reducing sample buffer with heating for five minutes at 95°C, followed by centrifugation (10000 g for 1 min). The supernatant containing the proteins was fractionated on slab gels (7.5% acrylamide separating gel; 5% stacking gel). Samples were examined under reducing conditions and electrophoresis was performed in 25 mM Tris (pH 8.3), 192 mM glycine, 0.1% SDS. Molecular weight markers (BenchMark Protein Ladder, Invitrogen) were also run. The gel was developed with MS-compatible silver stain using the protocol of <xref ref-type="bibr" rid="bib9">Blum et al., 1987</xref>. The band was excised in a laminar flow hood and submitted for mass spectrometry analysis (Alta Bioscience, UK).</p></sec><sec id="s4-24"><title>Identifying somite proteins that act as a substrate for S-nitrosylation</title><p>The Pierce S-Nitrosylation Western Blot Kit (ThermoFisher Scientific) was used, in which a lower background is obtained with iodoTMTzero reagent (Lot# PA19543) compared with biotin labelling. A cell free assay was prepared in which 650 somite strips were homogenized in HENS buffer [1 ml + 10 μl protease inhibitor cocktail (Sigma Lot# 033M4023V)] using an electrically-driven disposable pestle and grinding resin (GE Healthcare). Following centrifugation at 1000 g for 1 min at 10°C to remove the resin, the homogenate was centrifuged at 10,000 g for 20 min. Aliquots of homogenate containing 200 μg protein in 200 μl of HENS buffer made 200 μM with GSNO. Reduced glutathione was used as a negative control. After incubation at room temperature in the dark for 45 min, unreacted GSNO was removed using P6 microcolumns (BioRad) and the samples blocked with methyl methanethiosulfonate. Labelling with iodoTMT reagent was performed in the presence of sodium ascorbate and controls in the presence of water. Protein samples (48 μg) were fractionated on NuPAGE 4–12% Bis Tris gels in MOPS buffer and blotted onto Hybond C-extra nitrocellulose membrane using NuPAGE transfer buffer (Thermo Fisher Scientific) containing antioxidant. Blots were probed with anti-TMT antibody (1:1000, Lot#OH190916) purified from mouse ascites fluid with Pierce Goat Anti-Mouse IgG (H+L) HRP conjugate (Lot#OI192080).</p></sec><sec id="s4-25"><title>Identification of LC1 in somite extracts</title><p>An extract of stage 19/20 chick embryo trunks was prepared in HENS buffer containing protease inhibitor (as above for somite strips) and the protein content quantified. An aliquot containing 25 μg protein was fractionated on a 4–12% Bis-Tris gel and blotted onto Hybond C-extra nitrocellulose membrane using NuPAGE transfer buffer (Thermo Fisher Scientific) containing antioxidant. The blot was cut in half just above the 41K marker and the top half of the membrane was probed with rabbit anti-tubulin (Sigma, Lot#50K4813) followed by goat anti-rabbit IgG (HRP, Abcam Lot#GR3231028-7, 1:20,000). The bottom half was probed with MAP-1B (LC1) mouse monoclonal antibody against amino acids 2257–2357 of MAP-1B of mouse origin (Santa Cruz Biotechnology, Inc, sc-136472) followed by goat anti-mouse IgG (HRP, Pierce Lot#TE262980, 1:20,000). Blots were blocked in 5% non-fat dried milk (BioRad) in TBST and thoroughly washed x5, each for 5 min, in TBST. In both above experiments blots were treated with Millipore Immobilon Western Reagent (Lot#1710401) and exposed to film.</p></sec><sec id="s4-26"><title>Action of D-NAME and L-NAME on S-nitrosylation of LC1</title><p>Somite extract (200 μg protein for each condition) was incubated at 37°C for 1 hr in the presence of 300 μM D-NAME (Sigma, Lot#BCBM7105V) or L-NAME (Sigma, Lot#BCBT1028). A control experiment with somite extract and buffer alone was included. Subsequently extracts were made 200 μM in S-nitrosoglutathione and left at room temperature for 45 min before being processed as above and subjected to fractionation on a Nu-PAGE 4–12% Bis-Tris gel in MOPS buffer followed by blotting on Hybond C-extra. Care was taken to load equal amounts of protein (15 μg per lane). Processed samples were assayed for protein levels with a Qubit Fluorometer 2.0 (Thermo Fisher Scientific) using the Qubit protein assay (quantitation range 0.25–5 μg) to achieve the same quantity of sample in each lane. The blot was cut in half below the 53K molecular weight marker and the top half probed with rabbit anti-tubulin (Sigma, Lot#50K4813, 1:20,000) and goat anti-rabbit IgG (HRP, Abcam Lot#GR3231028-7) followed by Millipore Immobilon Western Reagent. The damp membrane was examined using an iBright FL1500 imaging system (Thermo Fisher Scientific) and the digital image caught directly by the instrument to authenticate that somite extract was loaded in every lane. The bottom half of the blot was probed with anti-iodoTMT (Lot#PH204668, 1:1000) and goat anti-mouse IgG (H+L) HRP, 1:20,000, followed by Clarity Western ECL substrate (mid-femtogram-level sensitivity, BioRad). The damp membrane was examined in the iBright FL1500 imaging system and the digital image captured.</p></sec><sec id="s4-27"><title>Western blot of rat cortical astrocyte cell surface proteins</title><p>Two month-old wild-type rats (Rattus norvegicus) were used as a source of neonatal rat cerebral cortical astrocytes. Four flasks of cortical astrocytes (in DMEM with 10% FBS and penicillin/streptomycin) at 95% confluence were subjected to biotinylation using a commercial ‘Cell Surface Protein Isolation Kit’ (ThermoScientific, Prod#89881, Lot#RD234938). Following labelling of the cell surface proteins with EZ-link-Sulfo-NHS-SS-Biotin reagent, the biotinylated proteins were captured on NeutrAvidin resin, washed thoroughly and the bound proteins released by cleavage of the S-S bond by treatment with freshly prepared SDS-PAGE sample buffer made 50 mM with respect to DTT. One-third of this eluate was fractionated by SDS-PAGE on a 7.5% polyacrylamide resolving gel (120 × 80mmx3mm; 5% stacking gel) and blotted onto Hybond C-extra nitrocellulose membrane (Amersham Biosciences Batch No. 319063) using 25 mM Tris (pH8.3), 192 mM glycine and 0.1% SDS electrophoresis buffer. The blot was blocked with 5% Blotting Grade Non Fat Dry Milk (BioRad) and developed with 1:20,000 anti-PDI (Sigma P7496) followed by 1:2000 Tidy Blot Western Blot Detection Reagent-HRP (BioRad, Batch#160129) and the use of Immobilon Western Chemiluminescent HRP substrate (Millipore).</p></sec><sec id="s4-28"><title>Assessment of reductase activity in purified PDI</title><p>Di-E-GSSG was prepared by the reaction of eosin isothiocyanate (Sigma-Aldrich) with L-glutathione oxidised (Sigma-Aldrich Lot#100K72765) as described in detail by <xref ref-type="bibr" rid="bib61">Raturi and Mutus, 2007</xref>. Four samples of PDI (4 µg) were incubated in 20 µl 100 mM potassium phosphate (pH7), made 1.5 µM with respect to calcium and magnesium chloride, with 20 µl packed PNA-agarose beads (Vector lot ZC0504) with a capacity to bind &gt;90 µg asialofetuin to 20 µl beads. The beads were kept at 5°C over 18 hr with intermittent mixing. Following centrifugation at 14,000 g for 5 min at 4°C and a further wash with 30 µl of buffer, the combined supernatant fluids were added to the reaction mixture to give a maximum concentration 128 nM PDI. Reductase activity was monitored as above (<xref ref-type="bibr" rid="bib61">Raturi and Mutus, 2007</xref>). Fluorescence was measured in a Biotronix Fluorometer (Electronics and Instrumentation Services for Biological Science, University of Cambridge).</p></sec><sec id="s4-29"><title>Statistics</title><p>A non-parametric Kruskal-Wallis one-way ANOVA was used for comparison of data sets. The Mann-Whitney U test was used for comparison between treatment conditions in collapse assays. For comparison between three or more data points a two-way ANOVA was performed, followed by a post-hoc Bonferroni correction. No statistical methods were used to predetermine sample size. Graphs and figures were produced with GraphPad Prism 7.0 and Adobe Photoshop CS6. Histograms show mean +/- s.e.m.; see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for statistical data.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank C Stern, M Bate, C Holt, RB Heap and O Paulsen for comments on the manuscript. The initial parts of this work were supported by grants from the Medical Research Council, the Wellcome Trust, and the Howard Hughes Medical Institute, and more recently by grants from the Rosetrees Trust and Trinity College, Cambridge. JS was also supported by a studentship from the International Spinal Research Trust; EW was in receipt of an Undergraduate Summer Vacation Research Scholarship from the Anatomical Society; GR-V was in receipt of an Amgen Foundation Summer Research Scholarship.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Supervision, Funding acquisition, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con15"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con16"><p>Data curation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Chick embryos were used for this work, and all experiments were carried out at earlier developmental stages than those that require ethical approval.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Statistical data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b–f</xref>; <xref ref-type="fig" rid="fig2">Figure 2b–g</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a–g,i,l,n,o</xref>; <xref ref-type="fig" rid="fig3">Figure 3a–h</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a–k</xref>; <xref ref-type="fig" rid="fig4">Figure 4a–e</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a–f,h</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54612-supp1-v3.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-54612-transrepform-v3.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published dataset was used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Parkkonen</surname><given-names>T</given-names></name><name><surname>Kivirikko</surname><given-names>KZ</given-names></name><name><surname>Pihlajaniemi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1988">1988</year><data-title>Molecular cloning of a multifunctional chicken protein acting as the prolyl 4-hydroxylase beta-subunit, protein disulphide-isomerase and a cellular thyroid-hormone-binding protein. Comparison of cDNA-deduced amino acid sequences with those in other species.</data-title><source>UniProtKB</source><pub-id assigning-authority="other" pub-id-type="accession" xlink:href="https://www.uniprot.org/uniprot/P09102">P09102</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Chaboissier</surname> <given-names>MC</given-names></name><name><surname>Martin</surname> <given-names>JF</given-names></name><name><surname>Schedl</surname> <given-names>A</given-names></name><name><surname>de Crombrugghe</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>2813</fpage><lpage>2828</lpage><pub-id pub-id-type="doi">10.1101/gad.1017802</pub-id><pub-id pub-id-type="pmid">12414734</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali Khan</surname> <given-names>H</given-names></name><name><surname>Mutus</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Protein disulfide isomerase a multifunctional protein with multiple physiological roles</article-title><source>Frontiers in Chemistry</source><volume>2</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.3389/fchem.2014.00070</pub-id><pub-id pub-id-type="pmid">25207270</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascenzi</surname> <given-names>P</given-names></name><name><surname>Brunori</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Myoglobin: a pseudo-enzymatic scavenger of nitric oxide</article-title><source>Biochemistry and Molecular Biology Education</source><volume>29</volume><fpage>183</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/S1470-8175(01)00082-0</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname> <given-names>G</given-names></name><name><surname>Chivatakarn</surname> <given-names>O</given-names></name><name><surname>Bonanomi</surname> <given-names>D</given-names></name><name><surname>Lettieri</surname> <given-names>K</given-names></name><name><surname>Franco</surname> <given-names>L</given-names></name><name><surname>Xia</surname> <given-names>C</given-names></name><name><surname>Stein</surname> <given-names>E</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name><name><surname>Pfaff</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Presenilin-dependent receptor processing is required for axon guidance</article-title><source>Cell</source><volume>144</volume><fpage>106</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.11.053</pub-id><pub-id pub-id-type="pmid">21215373</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayir</surname> <given-names>H</given-names></name><name><surname>Kochanek</surname> <given-names>PM</given-names></name><name><surname>Liu</surname> <given-names>SX</given-names></name><name><surname>Arroyo</surname> <given-names>A</given-names></name><name><surname>Osipov</surname> <given-names>A</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Wisniewski</surname> <given-names>S</given-names></name><name><surname>Adelson</surname> <given-names>PD</given-names></name><name><surname>Graham</surname> <given-names>SH</given-names></name><name><surname>Kagan</surname> <given-names>VE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: indirect association with intracranial pressure</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>23</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1097/01.WCB.0000040399.30600.E3</pub-id><pub-id pub-id-type="pmid">12500091</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benhar</surname> <given-names>M</given-names></name><name><surname>Forrester</surname> <given-names>MT</given-names></name><name><surname>Stamler</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protein denitrosylation: enzymatic mechanisms and cellular functions</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>10</volume><fpage>721</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1038/nrm2764</pub-id><pub-id pub-id-type="pmid">19738628</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname> <given-names>TA</given-names></name><name><surname>Edwards</surname> <given-names>BS</given-names></name><name><surname>Sklar</surname> <given-names>LA</given-names></name><name><surname>Rogelj</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes</article-title><source>The Journal of Immunology</source><volume>164</volume><fpage>4120</fpage><lpage>4129</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.8.4120</pub-id><pub-id pub-id-type="pmid">10754306</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname> <given-names>S</given-names></name><name><surname>Hong</surname> <given-names>PW</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Baum</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry</article-title><source>PNAS</source><volume>108</volume><fpage>10650</fpage><lpage>10655</lpage><pub-id pub-id-type="doi">10.1073/pnas.1017954108</pub-id><pub-id pub-id-type="pmid">21670307</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname> <given-names>H</given-names></name><name><surname>Beier</surname> <given-names>H</given-names></name><name><surname>Gross</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels</article-title><source>Electrophoresis</source><volume>8</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1002/elps.1150080203</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonn</surname> <given-names>F</given-names></name><name><surname>Bartel</surname> <given-names>J</given-names></name><name><surname>Büttner</surname> <given-names>K</given-names></name><name><surname>Hecker</surname> <given-names>M</given-names></name><name><surname>Otto</surname> <given-names>A</given-names></name><name><surname>Becher</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Picking vanished proteins from the void: how to collect and ship/share extremely dilute proteins in a reproducible and highly efficient manner</article-title><source>Analytical Chemistry</source><volume>86</volume><fpage>7421</fpage><lpage>7427</lpage><pub-id pub-id-type="doi">10.1021/ac501189j</pub-id><pub-id pub-id-type="pmid">24987932</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bron</surname> <given-names>R</given-names></name><name><surname>Vermeren</surname> <given-names>M</given-names></name><name><surname>Kokot</surname> <given-names>N</given-names></name><name><surname>Andrews</surname> <given-names>W</given-names></name><name><surname>Little</surname> <given-names>GE</given-names></name><name><surname>Mitchell</surname> <given-names>KJ</given-names></name><name><surname>Cohen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Boundary cap cells constrain spinal motor neuron somal migration at motor exit points by a semaphorin-plexin mechanism</article-title><source>Neural Development</source><volume>2</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-2-21</pub-id><pub-id pub-id-type="pmid">17971221</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Analysis of the early stages of trunk neural crest migration in avian embryos using monoclonal antibody HNK-1</article-title><source>Developmental Biology</source><volume>115</volume><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(86)90226-5</pub-id><pub-id pub-id-type="pmid">3516760</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmichael</surname> <given-names>DF</given-names></name><name><surname>Morin</surname> <given-names>JE</given-names></name><name><surname>Dixon</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Purification and characterization of a thiol:protein disulfide oxidoreductase from bovine liver</article-title><source>The Journal of Biological Chemistry</source><volume>252</volume><fpage>7163</fpage><lpage>7167</lpage><pub-id pub-id-type="pmid">903355</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciatto</surname> <given-names>C</given-names></name><name><surname>Bahna</surname> <given-names>F</given-names></name><name><surname>Zampieri</surname> <given-names>N</given-names></name><name><surname>VanSteenhouse</surname> <given-names>HC</given-names></name><name><surname>Katsamba</surname> <given-names>PS</given-names></name><name><surname>Ahlsen</surname> <given-names>G</given-names></name><name><surname>Harrison</surname> <given-names>OJ</given-names></name><name><surname>Brasch</surname> <given-names>J</given-names></name><name><surname>Jin</surname> <given-names>X</given-names></name><name><surname>Posy</surname> <given-names>S</given-names></name><name><surname>Vendome</surname> <given-names>J</given-names></name><name><surname>Ranscht</surname> <given-names>B</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Honig</surname> <given-names>B</given-names></name><name><surname>Shapiro</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>T-cadherin structures reveal a novel adhesive binding mechanism</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1781</pub-id><pub-id pub-id-type="pmid">20190755</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Jareonsettasin</surname> <given-names>P</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Growth cone collapse assay</article-title><source>Methods in Molecular Biology</source><volume>1162</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0777-9_6</pub-id><pub-id pub-id-type="pmid">24838959</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Cook</surname> <given-names>GMW</given-names></name><name><surname>Sousa</surname> <given-names>C</given-names></name><name><surname>Schaeffer</surname> <given-names>J</given-names></name><name><surname>Wiles</surname> <given-names>K</given-names></name><name><surname>Jareonsettasin</surname> <given-names>P</given-names></name><name><surname>Kalyanasundaram</surname> <given-names>A</given-names></name><name><surname>Walder</surname> <given-names>E</given-names></name><name><surname>Casper</surname> <given-names>C</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Chua</surname> <given-names>PW</given-names></name><name><surname>Riboni-Verri</surname> <given-names>G</given-names></name><name><surname>Raza</surname> <given-names>M</given-names></name><name><surname>Swaddiwudhipong</surname> <given-names>N</given-names></name><name><surname>Hui</surname> <given-names>A</given-names></name><name><surname>Abdullah</surname> <given-names>A</given-names></name><name><surname>Wajed</surname> <given-names>S</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of nerve growth and patterning by cell surface protein disulphide isomerase</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/838771</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>EC</given-names></name><name><surname>Müller</surname> <given-names>B</given-names></name><name><surname>Bonhoeffer</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Axonal guidance in the chick visual system: posterior tectal membranes induce collapse of growth cones from the temporal retina</article-title><source>Neuron</source><volume>4</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(90)90441-H</pub-id><pub-id pub-id-type="pmid">2310573</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JA</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Stern</surname> <given-names>CD</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Isolation from chick somites of a glycoprotein fraction that causes collapse of dorsal root ganglion growth cones</article-title><source>Neuron</source><volume>4</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(90)90439-M</pub-id><pub-id pub-id-type="pmid">2155629</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davy</surname> <given-names>A</given-names></name><name><surname>Soriano</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development</article-title><source>Developmental Biology</source><volume>304</volume><fpage>182</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.12.028</pub-id><pub-id pub-id-type="pmid">17223098</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dours-Zimmermann</surname> <given-names>MT</given-names></name><name><surname>Maurer</surname> <given-names>K</given-names></name><name><surname>Rauch</surname> <given-names>U</given-names></name><name><surname>Stoffel</surname> <given-names>W</given-names></name><name><surname>Fässler</surname> <given-names>R</given-names></name><name><surname>Zimmermann</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>7731</fpage><lpage>7742</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4158-08.2009</pub-id><pub-id pub-id-type="pmid">19535585</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eickholt</surname> <given-names>BJ</given-names></name><name><surname>Mackenzie</surname> <given-names>SL</given-names></name><name><surname>Graham</surname> <given-names>A</given-names></name><name><surname>Walsh</surname> <given-names>FS</given-names></name><name><surname>Doherty</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Evidence for collapsin-1 functioning in the control of neural crest migration in both trunk and hindbrain regions</article-title><source>Development</source><volume>126</volume><fpage>2181</fpage><lpage>2189</lpage><pub-id pub-id-type="pmid">10207143</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname> <given-names>AF</given-names></name><name><surname>Gallo</surname> <given-names>G</given-names></name><name><surname>Letourneau</surname> <given-names>PC</given-names></name><name><surname>McLoon</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Stabilization of growing retinal axons by the combined signaling of nitric oxide and brain-derived neurotrophic factor</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>1458</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-04-01458.2000</pub-id><pub-id pub-id-type="pmid">10662836</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Everson</surname> <given-names>WV</given-names></name><name><surname>Kao</surname> <given-names>WW-Y</given-names></name></person-group><year iso-8601-date="1997">1997</year><person-group person-group-type="editor"><name><surname>Guzman</surname> <given-names>N. A</given-names></name></person-group><source>In Prolyl Hydroxylase, Protein Disulfide Isomerase and Other Structurally Related Proteins</source><publisher-loc>New York</publisher-loc><publisher-name>CRC Press</publisher-name></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>A</given-names></name><name><surname>Kishida</surname> <given-names>MG</given-names></name><name><surname>Kimmel</surname> <given-names>CB</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Building the backbone: the development and evolution of vertebral patterning</article-title><source>Development</source><volume>142</volume><fpage>1733</fpage><lpage>1744</lpage><pub-id pub-id-type="doi">10.1242/dev.118950</pub-id><pub-id pub-id-type="pmid">25968309</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flögel</surname> <given-names>U</given-names></name><name><surname>Merx</surname> <given-names>MW</given-names></name><name><surname>Godecke</surname> <given-names>A</given-names></name><name><surname>Decking</surname> <given-names>UK</given-names></name><name><surname>Schrader</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Myoglobin: a scavenger of bioactive NO</article-title><source>PNAS</source><volume>98</volume><fpage>735</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1073/pnas.98.2.735</pub-id><pub-id pub-id-type="pmid">11136228</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallina</surname> <given-names>A</given-names></name><name><surname>Hanley</surname> <given-names>TM</given-names></name><name><surname>Mandel</surname> <given-names>R</given-names></name><name><surname>Trahey</surname> <given-names>M</given-names></name><name><surname>Broder</surname> <given-names>CC</given-names></name><name><surname>Viglianti</surname> <given-names>GA</given-names></name><name><surname>Ryser</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>50579</fpage><lpage>50588</lpage><pub-id pub-id-type="doi">10.1074/jbc.M204547200</pub-id><pub-id pub-id-type="pmid">12218051</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gammill</surname> <given-names>LS</given-names></name><name><surname>Gonzalez</surname> <given-names>C</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Guidance of trunk neural crest migration requires neuropilin 2/semaphorin 3F signaling</article-title><source>Development</source><volume>133</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1242/dev.02187</pub-id><pub-id pub-id-type="pmid">16319111</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>A</given-names></name><name><surname>David</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Neurite growth-inhibitory activity in the adult rat cerebral cortical gray matter</article-title><source>Journal of Neurobiology</source><volume>32</volume><fpage>671</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(19970620)32:7&lt;671::AID-NEU3&gt;3.0.CO;2-1</pub-id><pub-id pub-id-type="pmid">9183745</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname> <given-names>SM</given-names></name><name><surname>Truman</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of <italic>Drosophila</italic></article-title><source>Neuron</source><volume>20</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80436-5</pub-id><pub-id pub-id-type="pmid">9459444</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname> <given-names>RF</given-names></name><name><surname>Epstein</surname> <given-names>CJ</given-names></name><name><surname>Anfinsen</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver</article-title><source>The Journal of Biological Chemistry</source><volume>238</volume><fpage>628</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">13948694</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goplen</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Enger</surname> <given-names>PØ</given-names></name><name><surname>Tysnes</surname> <given-names>BB</given-names></name><name><surname>Terzis</surname> <given-names>AJ</given-names></name><name><surname>Laerum</surname> <given-names>OD</given-names></name><name><surname>Bjerkvig</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Protein disulfide isomerase expression is related to the invasive properties of malignant glioma</article-title><source>Cancer Research</source><volume>66</volume><fpage>9895</fpage><lpage>9902</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-4589</pub-id><pub-id pub-id-type="pmid">17047051</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname> <given-names>V</given-names></name><name><surname>Hamilton</surname> <given-names>HL</given-names></name></person-group><year iso-8601-date="1951">1951</year><article-title>A series of normal stages in the development of the chick embryo</article-title><source>Journal of Morphology</source><volume>88</volume><fpage>49</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/jmor.1050880104</pub-id><pub-id pub-id-type="pmid">24539719</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausman</surname> <given-names>RE</given-names></name><name><surname>Moscona</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Purification and characterization of the retina-specific cell-aggregating factor</article-title><source>PNAS</source><volume>72</volume><fpage>916</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1073/pnas.72.3.916</pub-id><pub-id pub-id-type="pmid">1055390</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>W</given-names></name><name><surname>Baas</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Microtubule reconfiguration during axonal retraction induced by nitric oxide</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>5982</fpage><lpage>5991</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-14-05982.2002</pub-id><pub-id pub-id-type="pmid">12122060</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname> <given-names>DT</given-names></name><name><surname>Patterson</surname> <given-names>SI</given-names></name><name><surname>Smith</surname> <given-names>DS</given-names></name><name><surname>Skene</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide</article-title><source>Nature</source><volume>366</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1038/366562a0</pub-id><pub-id pub-id-type="pmid">8255294</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffstrom</surname> <given-names>BG</given-names></name><name><surname>Kaplan</surname> <given-names>A</given-names></name><name><surname>Letso</surname> <given-names>R</given-names></name><name><surname>Schmid</surname> <given-names>RS</given-names></name><name><surname>Turmel</surname> <given-names>GJ</given-names></name><name><surname>Lo</surname> <given-names>DC</given-names></name><name><surname>Stockwell</surname> <given-names>BR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins</article-title><source>Nature Chemical Biology</source><volume>6</volume><fpage>900</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1038/nchembio.467</pub-id><pub-id pub-id-type="pmid">21079601</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname> <given-names>AB</given-names></name><name><surname>Kania</surname> <given-names>A</given-names></name><name><surname>Tran</surname> <given-names>TS</given-names></name><name><surname>Gu</surname> <given-names>C</given-names></name><name><surname>De Marco Garcia</surname> <given-names>N</given-names></name><name><surname>Lieberam</surname> <given-names>I</given-names></name><name><surname>Johnson</surname> <given-names>D</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Ginty</surname> <given-names>DD</given-names></name><name><surname>Kolodkin</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Distinct roles for secreted semaphorin signaling in spinal motor axon guidance</article-title><source>Neuron</source><volume>48</volume><fpage>949</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.12.003</pub-id><pub-id pub-id-type="pmid">16364899</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janiszewski</surname> <given-names>M</given-names></name><name><surname>Lopes</surname> <given-names>LR</given-names></name><name><surname>Carmo</surname> <given-names>AO</given-names></name><name><surname>Pedro</surname> <given-names>MA</given-names></name><name><surname>Brandes</surname> <given-names>RP</given-names></name><name><surname>Santos</surname> <given-names>CX</given-names></name><name><surname>Laurindo</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>40813</fpage><lpage>40819</lpage><pub-id pub-id-type="doi">10.1074/jbc.M509255200</pub-id><pub-id pub-id-type="pmid">16150729</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasuja</surname> <given-names>R</given-names></name><name><surname>Passam</surname> <given-names>FH</given-names></name><name><surname>Kennedy</surname> <given-names>DR</given-names></name><name><surname>Kim</surname> <given-names>SH</given-names></name><name><surname>van Hessem</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>L</given-names></name><name><surname>Bowley</surname> <given-names>SR</given-names></name><name><surname>Joshi</surname> <given-names>SS</given-names></name><name><surname>Dilks</surname> <given-names>JR</given-names></name><name><surname>Furie</surname> <given-names>B</given-names></name><name><surname>Furie</surname> <given-names>BC</given-names></name><name><surname>Flaumenhaft</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>2104</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1172/JCI61228</pub-id><pub-id pub-id-type="pmid">22565308</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapfhammer</surname> <given-names>JP</given-names></name><name><surname>Raper</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Collapse of growth cone structure on contact with specific neurites in culture</article-title><source>The Journal of Neuroscience</source><volume>7</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.07-01-00201.1987</pub-id><pub-id pub-id-type="pmid">3543248</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keynes</surname> <given-names>RJ</given-names></name><name><surname>Johnson</surname> <given-names>AR</given-names></name><name><surname>Picart</surname> <given-names>CJ</given-names></name><name><surname>Dunin-Borkowski</surname> <given-names>OM</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>A growth cone collapsing activity in chicken gray matter</article-title><source>Annals of the New York Academy of Sciences</source><volume>633</volume><elocation-id>562</elocation-id><pub-id pub-id-type="doi">10.1111/j.1749-6632.1991.tb15661.x</pub-id><pub-id pub-id-type="pmid">1789581</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keynes</surname> <given-names>R</given-names></name><name><surname>Tannahill</surname> <given-names>D</given-names></name><name><surname>Morgenstern</surname> <given-names>DA</given-names></name><name><surname>Johnson</surname> <given-names>AR</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Pini</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Surround repulsion of spinal sensory axons in higher vertebrate embryos</article-title><source>Neuron</source><volume>18</volume><fpage>889</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80329-3</pub-id><pub-id pub-id-type="pmid">9208857</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keynes</surname> <given-names>RJ</given-names></name><name><surname>Stern</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Segmentation in the vertebrate nervous system</article-title><source>Nature</source><volume>310</volume><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/310786a0</pub-id><pub-id pub-id-type="pmid">6472458</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koblar</surname> <given-names>SA</given-names></name><name><surname>Krull</surname> <given-names>CE</given-names></name><name><surname>Pasquale</surname> <given-names>EB</given-names></name><name><surname>McLennan</surname> <given-names>R</given-names></name><name><surname>Peale</surname> <given-names>FD</given-names></name><name><surname>Cerretti</surname> <given-names>DP</given-names></name><name><surname>Bothwell</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Spinal motor axons and neural crest cells use different molecular guides for segmental migration through the rostral half-somite</article-title><source>Journal of Neurobiology</source><volume>42</volume><fpage>437</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(200003)42:4&lt;437::AID-NEU5&gt;3.0.CO;2-O</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozlov</surname> <given-names>G</given-names></name><name><surname>Määttänen</surname> <given-names>P</given-names></name><name><surname>Thomas</surname> <given-names>DY</given-names></name><name><surname>Gehring</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A structural overview of the PDI family of proteins</article-title><source>FEBS Journal</source><volume>277</volume><fpage>3924</fpage><lpage>3936</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07793.x</pub-id><pub-id pub-id-type="pmid">20796029</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krull</surname> <given-names>CE</given-names></name><name><surname>Lansford</surname> <given-names>R</given-names></name><name><surname>Gale</surname> <given-names>NW</given-names></name><name><surname>Collazo</surname> <given-names>A</given-names></name><name><surname>Marcelle</surname> <given-names>C</given-names></name><name><surname>Yancopoulos</surname> <given-names>GD</given-names></name><name><surname>Fraser</surname> <given-names>SE</given-names></name><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration</article-title><source>Current Biology</source><volume>7</volume><fpage>571</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(06)00256-9</pub-id><pub-id pub-id-type="pmid">9259560</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuan</surname> <given-names>CY</given-names></name><name><surname>Tannahill</surname> <given-names>D</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Somite polarity and segmental patterning of the peripheral nervous system</article-title><source>Mechanisms of Development</source><volume>121</volume><fpage>1055</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2004.05.001</pub-id><pub-id pub-id-type="pmid">15296971</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname> <given-names>KH</given-names></name><name><surname>Stawski</surname> <given-names>PS</given-names></name><name><surname>Draycott</surname> <given-names>AS</given-names></name><name><surname>Udeshi</surname> <given-names>ND</given-names></name><name><surname>Lehrman</surname> <given-names>EK</given-names></name><name><surname>Wilton</surname> <given-names>DK</given-names></name><name><surname>Svinkina</surname> <given-names>T</given-names></name><name><surname>Deerinck</surname> <given-names>TJ</given-names></name><name><surname>Ellisman</surname> <given-names>MH</given-names></name><name><surname>Stevens</surname> <given-names>B</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Ting</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Proteomic analysis of unbounded cellular compartments: synaptic clefts</article-title><source>Cell</source><volume>166</volume><fpage>1295</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.041</pub-id><pub-id pub-id-type="pmid">27565350</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manns</surname> <given-names>RP</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Holt</surname> <given-names>CE</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differing semaphorin 3A concentrations trigger distinct signaling mechanisms in growth cone collapse</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>8554</fpage><lpage>8559</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5964-11.2012</pub-id><pub-id pub-id-type="pmid">22723695</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massy</surname> <given-names>ZA</given-names></name><name><surname>Borderie</surname> <given-names>D</given-names></name><name><surname>Nguyen-Khoa</surname> <given-names>T</given-names></name><name><surname>Drüeke</surname> <given-names>TB</given-names></name><name><surname>Ekindjian</surname> <given-names>OG</given-names></name><name><surname>Lacour</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Increased plasma S-nitrosothiol levels in chronic haemodialysis patients</article-title><source>Nephrology Dialysis Transplantation</source><volume>18</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1093/ndt/18.1.153</pub-id><pub-id pub-id-type="pmid">12480974</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname> <given-names>A</given-names></name><name><surname>Maaß</surname> <given-names>S</given-names></name><name><surname>Bonn</surname> <given-names>F</given-names></name><name><surname>Büttner</surname> <given-names>K</given-names></name><name><surname>Becher</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An easy and fast protocol for affinity Bead-Based protein enrichment and storage of proteome samples</article-title><source>Methods in Enzymology</source><volume>585</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2016.09.012</pub-id><pub-id pub-id-type="pmid">28109424</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Owen</surname> <given-names>JB</given-names></name><name><surname>Butterfield</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2010">2010</year><chapter-title><italic>Protein Misfolding and Cellular Stress in Disease and Aging</italic></chapter-title><person-group person-group-type="editor"><name><surname>Bross</surname> <given-names>P</given-names></name><name><surname>Gregersen</surname> <given-names>N</given-names></name></person-group><source>Concepts and Protocols</source><publisher-name>Springer Science &amp; Business Media</publisher-name><fpage>269</fpage><lpage>277</lpage></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>GD</given-names></name><name><surname>Attur</surname> <given-names>MG</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Moon</surname> <given-names>P</given-names></name><name><surname>Beier</surname> <given-names>F</given-names></name><name><surname>Abramson</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>F-spondin deficient mice have a high bone mass phenotype</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98388</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098388</pub-id><pub-id pub-id-type="pmid">24875054</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parakh</surname> <given-names>S</given-names></name><name><surname>Atkin</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel roles for protein disulphide isomerase in disease states: a double edged sword?</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>3</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2015.00030</pub-id><pub-id pub-id-type="pmid">26052512</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pariser</surname> <given-names>HP</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Hausman</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The cell adhesion molecule retina cognin is a cell surface protein disulfide isomerase that uses disulfide exchange activity to modulate cell adhesion</article-title><source>Experimental Cell Research</source><volume>258</volume><fpage>42</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1006/excr.2000.4931</pub-id><pub-id pub-id-type="pmid">10912786</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perissinotto</surname> <given-names>D</given-names></name><name><surname>Iacopetti</surname> <given-names>P</given-names></name><name><surname>Bellina</surname> <given-names>I</given-names></name><name><surname>Doliana</surname> <given-names>R</given-names></name><name><surname>Colombatti</surname> <given-names>A</given-names></name><name><surname>Pettway</surname> <given-names>Z</given-names></name><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name><name><surname>Shinomura</surname> <given-names>T</given-names></name><name><surname>Kimata</surname> <given-names>K</given-names></name><name><surname>Mörgelin</surname> <given-names>M</given-names></name><name><surname>Löfberg</surname> <given-names>J</given-names></name><name><surname>Perris</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan</article-title><source>Development</source><volume>127</volume><fpage>2823</fpage><lpage>2842</lpage><pub-id pub-id-type="pmid">10851128</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Primm</surname> <given-names>TP</given-names></name><name><surname>Gilbert</surname> <given-names>HF</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Hormone binding by protein disulfide isomerase, a high capacity hormone reservoir of the endoplasmic reticulum</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1074/jbc.M007670200</pub-id><pub-id pub-id-type="pmid">11035025</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname> <given-names>N</given-names></name><name><surname>Root</surname> <given-names>P</given-names></name><name><surname>Jiang</surname> <given-names>XM</given-names></name><name><surname>Hogg</surname> <given-names>PJ</given-names></name><name><surname>Mutus</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase</article-title><source>PNAS</source><volume>98</volume><fpage>9539</fpage><lpage>9544</lpage><pub-id pub-id-type="doi">10.1073/pnas.171180998</pub-id><pub-id pub-id-type="pmid">11493694</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranscht</surname> <given-names>B</given-names></name><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo</article-title><source>Development</source><volume>111</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">1707785</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raper</surname> <given-names>JA</given-names></name><name><surname>Kapfhammer</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>The enrichment of a neuronal growth cone collapsing activity from embryonic chick brain</article-title><source>Neuron</source><volume>4</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(90)90440-Q</pub-id><pub-id pub-id-type="pmid">2155630</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raturi</surname> <given-names>A</given-names></name><name><surname>Mutus</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay</article-title><source>Free Radical Biology and Medicine</source><volume>43</volume><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.03.025</pub-id><pub-id pub-id-type="pmid">17561094</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayner</surname> <given-names>BS</given-names></name><name><surname>Hua</surname> <given-names>S</given-names></name><name><surname>Sabaretnam</surname> <given-names>T</given-names></name><name><surname>Witting</surname> <given-names>PK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nitric oxide stimulates myoglobin gene and protein expression in vascular smooth muscle</article-title><source>Biochemical Journal</source><volume>423</volume><fpage>169</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1042/BJ20090716</pub-id><pub-id pub-id-type="pmid">19650765</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rickmann</surname> <given-names>M</given-names></name><name><surname>Fawcett</surname> <given-names>JW</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The migration of neural crest cells and the growth of motor axons through the rostral half of the chick somite</article-title><source>Journal of Embryology and Experimental Morphology</source><volume>90</volume><fpage>437</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">3834038</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogelj</surname> <given-names>S</given-names></name><name><surname>Reiter</surname> <given-names>KJ</given-names></name><name><surname>Kesner</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Essex</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Enzyme destruction by a protease contaminant in bacitracin</article-title><source>Biochemical and Biophysical Research Communications</source><volume>273</volume><fpage>829</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2000.3029</pub-id><pub-id pub-id-type="pmid">10891332</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname> <given-names>K</given-names></name><name><surname>Webb</surname> <given-names>NE</given-names></name><name><surname>Pang</surname> <given-names>M</given-names></name><name><surname>Hernandez-Davies</surname> <given-names>JE</given-names></name><name><surname>Lee</surname> <given-names>KP</given-names></name><name><surname>Gonzalez</surname> <given-names>P</given-names></name><name><surname>Douglass</surname> <given-names>MV</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Baum</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Galectin-9 binds to O-glycans on protein disulfide isomerase</article-title><source>Glycobiology</source><volume>27</volume><fpage>878</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwx065</pub-id><pub-id pub-id-type="pmid">28810662</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname> <given-names>J</given-names></name><name><surname>Tannahill</surname> <given-names>D</given-names></name><name><surname>Cioni</surname> <given-names>JM</given-names></name><name><surname>Rowlands</surname> <given-names>D</given-names></name><name><surname>Keynes</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of the extracellular matrix protein Fibulin-2 as a regulator of spinal nerve organization</article-title><source>Developmental Biology</source><volume>442</volume><fpage>101</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.06.014</pub-id><pub-id pub-id-type="pmid">29944871</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>Q</given-names></name><name><surname>Maden</surname> <given-names>CH</given-names></name><name><surname>Davidson</surname> <given-names>K</given-names></name><name><surname>Ruhrberg</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia</article-title><source>Development</source><volume>136</volume><fpage>1785</fpage><lpage>1789</lpage><pub-id pub-id-type="doi">10.1242/dev.034322</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>CM</given-names></name><name><surname>Bell</surname> <given-names>SE</given-names></name><name><surname>Locke</surname> <given-names>IC</given-names></name><name><surname>Chowdrey</surname> <given-names>HS</given-names></name><name><surname>Gordge</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Interactions between cell surface protein disulphide isomerase and S-nitrosoglutathione during nitric oxide delivery</article-title><source>Nitric Oxide</source><volume>16</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2006.08.001</pub-id><pub-id pub-id-type="pmid">16990041</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name><name><surname>Chen</surname> <given-names>DF</given-names></name><name><surname>Xia</surname> <given-names>W</given-names></name><name><surname>Selkoe</surname> <given-names>DJ</given-names></name><name><surname>Tonegawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Skeletal and CNS defects in Presenilin-1-deficient mice</article-title><source>Cell</source><volume>89</volume><fpage>629</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80244-5</pub-id><pub-id pub-id-type="pmid">9160754</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname> <given-names>I</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Raper</surname> <given-names>JA</given-names></name><name><surname>Chang</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The distribution of collapsin-1 mRNA in the developing chick nervous system</article-title><source>Developmental Biology</source><volume>173</volume><fpage>185</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1006/dbio.1996.0016</pub-id><pub-id pub-id-type="pmid">8575620</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliskovic</surname> <given-names>I</given-names></name><name><surname>Raturi</surname> <given-names>A</given-names></name><name><surname>Mutus</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Characterization of the S-denitrosation activity of protein disulfide isomerase</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>8733</fpage><lpage>8741</lpage><pub-id pub-id-type="doi">10.1074/jbc.M408080200</pub-id><pub-id pub-id-type="pmid">15611098</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobierajska</surname> <given-names>K</given-names></name><name><surname>Skurzynski</surname> <given-names>S</given-names></name><name><surname>Stasiak</surname> <given-names>M</given-names></name><name><surname>Kryczka</surname> <given-names>J</given-names></name><name><surname>Cierniewski</surname> <given-names>CS</given-names></name><name><surname>Swiatkowska</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Protein disulfide isomerase directly interacts with β-actin Cys374 and regulates cytoskeleton reorganization</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>5758</fpage><lpage>5773</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.479477</pub-id><pub-id pub-id-type="pmid">24415753</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steketee</surname> <given-names>MB</given-names></name><name><surname>Tosney</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Contact with isolated sclerotome cells steers sensory growth cones by altering distinct elements of extension</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>3495</fpage><lpage>3506</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-09-03495.1999</pub-id><pub-id pub-id-type="pmid">10212309</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname> <given-names>CD</given-names></name><name><surname>Sisodiya</surname> <given-names>SM</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Interactions between neurites and somite cells: inhibition and stimulation of nerve growth in the chick embryo</article-title><source>Journal of Embryology and Experimental Morphology</source><volume>91</volume><fpage>209</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">3519826</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolt</surname> <given-names>CC</given-names></name><name><surname>Lommes</surname> <given-names>P</given-names></name><name><surname>Sock</surname> <given-names>E</given-names></name><name><surname>Chaboissier</surname> <given-names>MC</given-names></name><name><surname>Schedl</surname> <given-names>A</given-names></name><name><surname>Wegner</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The Sox9 transcription factor determines glial fate choice in the developing spinal cord</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>1677</fpage><lpage>1689</lpage><pub-id pub-id-type="doi">10.1101/gad.259003</pub-id><pub-id pub-id-type="pmid">12842915</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroissnigg</surname> <given-names>H</given-names></name><name><surname>Trancíková</surname> <given-names>A</given-names></name><name><surname>Descovich</surname> <given-names>L</given-names></name><name><surname>Fuhrmann</surname> <given-names>J</given-names></name><name><surname>Kutschera</surname> <given-names>W</given-names></name><name><surname>Kostan</surname> <given-names>J</given-names></name><name><surname>Meixner</surname> <given-names>A</given-names></name><name><surname>Nothias</surname> <given-names>F</given-names></name><name><surname>Propst</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction</article-title><source>Nature Cell Biology</source><volume>9</volume><fpage>1035</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1038/ncb1625</pub-id><pub-id pub-id-type="pmid">17704770</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Cornwell</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Peng</surname> <given-names>S</given-names></name><name><surname>Osorio</surname> <given-names>MJ</given-names></name><name><surname>Aalling</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Benraiss</surname> <given-names>A</given-names></name><name><surname>Lou</surname> <given-names>N</given-names></name><name><surname>Goldman</surname> <given-names>SA</given-names></name><name><surname>Nedergaard</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SOX9 is an Astrocyte-Specific nuclear marker in the adult brain outside the neurogenic regions</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>4493</fpage><lpage>4507</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3199-16.2017</pub-id><pub-id pub-id-type="pmid">28336567</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzarfati-Majar</surname> <given-names>V</given-names></name><name><surname>Burstyn-Cohen</surname> <given-names>T</given-names></name><name><surname>Klar</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>F-spondin is a contact-repellent molecule for embryonic motor neurons</article-title><source>PNAS</source><volume>98</volume><fpage>4722</fpage><lpage>4727</lpage><pub-id pub-id-type="doi">10.1073/pnas.081062398</pub-id><pub-id pub-id-type="pmid">11287656</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermeren</surname> <given-names>MM</given-names></name><name><surname>Cook</surname> <given-names>GM</given-names></name><name><surname>Johnson</surname> <given-names>AR</given-names></name><name><surname>Keynes</surname> <given-names>RJ</given-names></name><name><surname>Tannahill</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Spinal nerve segmentation in the chick embryo: analysis of distinct axon-repulsive systems</article-title><source>Developmental Biology</source><volume>225</volume><fpage>241</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1006/dbio.2000.9820</pub-id><pub-id pub-id-type="pmid">10964478</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>HU</given-names></name><name><surname>Anderson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth</article-title><source>Neuron</source><volume>18</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)81240-4</pub-id><pub-id pub-id-type="pmid">9115733</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>H</given-names></name><name><surname>Yamada</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Chondrodysplasia of gene knockout mice for aggrecan and link protein</article-title><source>Glycoconjugate Journal</source><volume>19</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1023/A:1025344332099</pub-id><pub-id pub-id-type="pmid">12975605</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="1998">1998</year><source>In Situ Hybridization: A Practical Approach</source><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>PC</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Becher</surname> <given-names>MW</given-names></name><name><surname>Sirinathsinghji</surname> <given-names>DJ</given-names></name><name><surname>Trumbauer</surname> <given-names>ME</given-names></name><name><surname>Chen</surname> <given-names>HY</given-names></name><name><surname>Price</surname> <given-names>DL</given-names></name><name><surname>Van der Ploeg</surname> <given-names>LH</given-names></name><name><surname>Sisodia</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm</article-title><source>Nature</source><volume>387</volume><fpage>288</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1038/387288a0</pub-id><pub-id pub-id-type="pmid">9153393</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>HH</given-names></name><name><surname>Williams</surname> <given-names>CV</given-names></name><name><surname>McLoon</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Involvement of nitric oxide in the elimination of a transient retinotectal projection in development</article-title><source>Science</source><volume>265</volume><fpage>1593</fpage><lpage>1596</lpage><pub-id pub-id-type="doi">10.1126/science.7521541</pub-id><pub-id pub-id-type="pmid">7521541</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>G</given-names></name><name><surname>Chung</surname> <given-names>TF</given-names></name><name><surname>Pyun</surname> <given-names>HY</given-names></name><name><surname>Fine</surname> <given-names>RE</given-names></name><name><surname>Johnson</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>KDEL proteins are found on the surface of NG108-15 cells</article-title><source>Molecular Brain Research</source><volume>72</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/S0169-328X(99)00188-6</pub-id><pub-id pub-id-type="pmid">10529470</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Butkevich</surname> <given-names>AN</given-names></name><name><surname>Yamada</surname> <given-names>R</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Debnath</surname> <given-names>B</given-names></name><name><surname>Duncan</surname> <given-names>R</given-names></name><name><surname>Zandi</surname> <given-names>E</given-names></name><name><surname>Petasis</surname> <given-names>NA</given-names></name><name><surname>Neamati</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian Cancer treatment</article-title><source>PNAS</source><volume>109</volume><fpage>16348</fpage><lpage>16353</lpage><pub-id pub-id-type="doi">10.1073/pnas.1205226109</pub-id><pub-id pub-id-type="pmid">22988091</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zai</surname> <given-names>A</given-names></name><name><surname>Rudd</surname> <given-names>MA</given-names></name><name><surname>Scribner</surname> <given-names>AW</given-names></name><name><surname>Loscalzo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide</article-title><source>Journal of Clinical Investigation</source><volume>103</volume><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1172/JCI4890</pub-id><pub-id pub-id-type="pmid">9927500</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zito</surname> <given-names>E</given-names></name><name><surname>Melo</surname> <given-names>EP</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Wahlander</surname> <given-names>Å</given-names></name><name><surname>Neubert</surname> <given-names>TA</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin</article-title><source>Molecular Cell</source><volume>40</volume><fpage>787</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.11.010</pub-id><pub-id pub-id-type="pmid">21145486</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54612.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Mason</surname><given-names>Carol A</given-names></name><role>Reviewing Editor</role><aff><institution>Columbia University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Rajnicek</surname><given-names>Ann</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This excellent study reveals a mechanism for how growth of sensory and motor axons is restricted to the anterior half of each somite-derived sclerotome in the spinal cord, during generation of the segmented patterning of nerves during early peripheral nervous system development. The authors show that the cell surface protein disulphide isomerase contributes to such axonal segmentation by serving as an impenetrable barrier for growth cones in the posterior somite through acting on a nitric oxide/S-nitrosylation-dependent signal transduction pathway regulating the growth cone cytoskeleton, inducing axon growth cones to traverse the anterior half of each somite as they extend towards their body targets.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Regulation of nerve growth and patterning by cell surface protein disulphide isomerase&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Ann Rajnicek (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Your study on how the growth of sensory and motor axons are restricted to the anterior half of each somite-derived sclerotome, generating the segmented patterning of the early PNS, was viewed favorably by the reviewers. The demonstration of a key role for cell surface protein disulphide isomerase (PDI) via an NO-based mechanism in the establishment of such segmental axon patterning was deemed a major and important contribution. To ensure that the manuscript is accessible to the wide audience of <italic>eLife</italic> and to be clear even to developmental biologists, the reviewers and I ask that you insert a diagram in the first figure that would depict the somite arrangements and axon tracts, to set out the hypothesis, then a summary diagram in a final figure that would pull together the various strands of the results. Also, the reviewers call for examples of growth cone collapse and time course images, and for minor text modifications. I have left the reviews intact so that you can read the many positive comments on your study.</p><p>Essential revisions:</p><p>All of the revisions requested below are essential, and none call for performing new experiments.</p><p><italic>Reviewer #1:</italic></p><p>The restriction of the growth of sensory and motor axons to the anterior half of each somite-derived sclerotome, generating the segmented patterning of the early PNS, and the demonstration that this is due to contact repulsion exerted by the posterior sclerotome cells is one of the first and classic examples of this fundamental axon guidance mechanism. However, the molecular basis of segmental patterning is not understood. Here Cook and colleagues provide evidence for a key role for cell surface protein disulphide isomerase (PDI) via an NO-based mechanism in the establishment of segmental axon patterning and as such make a major and important contribution to our understanding.</p><p>Because they have previously shown that the lectin peanut agglutinin (PNA) binds to the posterior half sclerotome cells and that immobilised PNA depletes the collapse activity of the posterior sclerotome which is recovered by lactose elution, they subjected a major band in silver-stained SDS PAGE preparations of lactose elutes to tryptic digestion and mass spectrometry. This revealed numerous peptides distributed throughout PDIA1/P4HB, a member of the PDI family. They additionally showed that PDI staining appears in the posterior sclerotome shortly before the segmental emergence of sensory and motor axons. Importantly, they showed that in ovo microinjection of PDI siRNA, but not a scrambled control, disrupted the segmental patterning of early axons. As an alternative demonstration of the role of PDI, they microinjected a molecule that has been shown to specifically disrupt one of the active sites of PDI. Like PDI siRNA, this too disrupted segmental axon growth. To elucidate how PDI causes growth cone collapse, they investigated the potential involvement of an NO, based on the previous demonstration that NO causes growth cone collapse and that PDS catalyses NO entry by a transnitrosation mechanism. They showed in a DRG growth cone collapse assay that PDI (but not inhibited PDI) promotes NO donor-induced collapse. Moreover, somite extract-induced collapse was prevented by pre-treating DRG with an NOS inhibitor. Because S-nitrosylation of the MAPB1 light chain subunit LC1 has been shown to mediates calcium ionophore-induced growth cone collapse, they investigated whether a similar mechanism occurs in somite-induced growth cone collapse. Western blotting revealed that only one band, that corresponds to LC1, was S-nitrosylated in dissected somite strips and that S-nitrosylation of this band was prevented by an NOS inhibitor. Finally, they showed that PDI is expressed on mature astrocytes and that the growth cone collapsing activity of the grey matter of mature mammalian brain is blocked by inhibitors of PDI activity, suggesting that a similar mechanism operates in the CNS.</p><p>It is unfortunate that the chicken lacks suitable transgenetic tools, so well developed in mice, to demonstrate conclusively the role of PDI in segmental axon patterning. Nonetheless, the authors have done what is acceptable to show beyond reasonable doubt the role of PDI in segmental axon patterning and its mechanism of action in the developing chicken embryo. This is an important, far-reaching study. Many of the experiments are truly heroic given the very small quantity of tissue available. The results are well-controlled and logically presented and the paper is very well written. I have no major criticisms.</p><p><italic>Reviewer #2:</italic></p><p>This is a careful study in which a plethora of methodologies are used to dissect the molecular mechanisms by which cell surface protein disulphide isomerase underpins sensory axon segmentation of spinal neurons. It has important implications not just for developmental neuroscience but also for potential strategies to improve recalcitrant neuron growth in the mammalian central nervous system.</p><p>Overall the manuscript is well written and clearly organised into a sequence of logical experiments. It is evident that the authors have substantial expertise in the subject area. However, there are a few things that I would like to see addressed.</p><p>1) In terms of figure presentation, I think it would help enormously to have cartoons of the somite arrangements and the axon tracks coupled with the key molecular cues to set the stage for the study. That is, to describe the anatomy in a classical developmental biology/anatomy context. I don't think this is a minor point. <italic>eLife</italic> is a journal with a wide audience and the paper is written from the viewpoint of a hard-core developmental neuroscientist, which shows deep understanding of the specialist area, but which might make the paper inaccessible to a larger audience. A summary figure to set out the hypothesis in a first figure, coupled with a summary diagram in a final figure pulling together the various strands of the results would be incredibly useful. Both because of the wide range of specialist techniques used in the study and because there is a wider context in which the study could be interpreted- but there is a lot to digest from the text and the point is difficult to grasp in places.</p><p>2) The authors say that ….'co-injection of siRNA…rescued the normal segmented phenotype (Figure 2….)'. But looking at the data in the figure I think it is best to say that the phenotype was rescued partially.</p><p>3) A major point of the paper is that the authors have identified a growth cone collapse mechanism and they use a collapse assay (collected data are based on morphology) but there are no photographs of the growth cones in any of the figures. It would be useful to have images so the reader can get a feel for what 'collapse' looks like, especially with respect to soluble and contact mediated factors. For example, when the growth cones are challenged with soluble factors or liposomes: how do liposomes interact physically with filopodia in these cultures as compared to soluble factor influences on growth cone morphology (important because, as the authors state, a single filopodial contact can make all the difference)? They report time course data, so they must have time lapse images of growth cones as they collapse from which such measurements were made. These would be useful for the reader.</p><p>4) In a similar vein, given the importance of growth cone collapse and the role of the identified molecular mechanism on axon pathfinding I'm wondering why the authors did not include 'classical growth cone turning assay' or 'stripe assay' experiments. I am not necessarily requesting additional experiments, but if the authors have such data they would add to the study.</p><p><italic>Reviewer #3:</italic></p><p>In this interesting manuscript, Cook and colleagues provide a kind of closure to a long-standing question about patterning of metameric nerve growth in avian and mammalian embryos. Previous studies, many from the Keynes laboratory, showed that although both neural crest cells and motor and sensory axons traverse only the anterior half somite during outgrowth, the underlying molecular mechanisms that channel neural crest cell migration are distinct from those that channel axon extension. Here, they identify PDIA1/P4HB, a protein disulphide isomerase, as the cell surface activity required to prevent axons from entering the posterior half somite. They demonstrate that this PDI mediates axon repulsion by activating nitric oxide signaling, which elicits growth cone collapse. The also show that this PDI is the activity from adult brain extracts previously shown to mediate sensory axon growth cone collapse, and that this activity may emanate from astroglia.</p><p>This manuscript provides a satisfying answer to a question that has long been elusive. For the most part the data are very robust and well-documented. However, I suggest two types of improvements. First, other molecules, including ones described by the Keynes laboratory, are also implicated in preventing axons from entering the posterior half somite. This should be discussed. I think it would be very helpful to include a model figure that shows how PDI operates, as they describe in the Discussion, and also includes these other molecular mechanisms. Second, a number of figures could be improved.</p><p>1) Figure 1: It would be helpful to box the regions blown up in D-F.</p><p>2) Figure 1—figure supplement 1: It's very difficult to see what's going on in panel C. Asterisks or some other marker would help.</p><p>3) Figure 2: Is the loss of PDI random in these experiments? It looks like after siRNA it is gone in some somites and still present in others. Is this consistent? If so, how do you know whether it is effective?</p><p>4) Figure 2—figure supplement 2. It would be very helpful to show a blow up with comparisons for panel H.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for submitting your article &quot;Regulation of nerve growth and patterning by cell surface protein disulphide isomerase&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor The following individual involved in review of your submission has agreed to reveal their identity: Alun M Davies (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>Summary:</p><p>All three reviewers were enthusiastic about your study dissecting the molecular mechanisms by which the cell surface protein disulphide isomerase contributes to segmentation of sensory axons of spinal neurons. The study should appeal both to developmental biologists and those who study neuronal pathologies.</p><p>Reviewer 1 stated that &quot;this is an excellent study that has been further improved by the revisions. The authors are to be congratulated on their achievements&quot; and had no further comments at this stage. Reviewers 2 and 3 stated that the manuscript has been improved, and that you addressed the suggestions made and issues raised.</p><p>Essential revisions:</p><p>While reviewers 2 and 3 found that the changes to the figures, especially Figure 1, clarified the experimental outcomes and interpretation, there were three remaining amendments suggested:</p><p>1) In the figure legend for new Figure 1, you refer to '…mixed spinal nerves (yellow) but there is no yellow in the figure. Neither the arrow pointing to the nerve nor the nerve itself is yellow, so you may want to amend this.</p><p>2) New Figure 5 is also helpful, but reviewer 3 found the large red arrow at the bottom confusing. Is this meant to indicate retraction? If so, that should be described in the legend.</p><p>3) Reviewer 3 wonders why the you chose not to include an image of a collapsed growth cone, as suggested originally by reviewer 2. This would make the article more accessible to readers, without them having to look at additional references.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54612.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>All of the revisions requested below are essential, and none call for performing new experiments.</p><p>Reviewer #1:</p><p>The restriction of the growth of sensory and motor axons to the anterior half of each somite-derived sclerotome, generating the segmented patterning of the early PNS, and the demonstration that this is due to contact repulsion exerted by the posterior sclerotome cells is one of the first and classic examples of this fundamental axon guidance mechanism. […] The results are well-controlled and logically presented and the paper is very well written. I have no major criticisms.</p></disp-quote><p>The reviewer raises no major criticisms, and regards the study as a 'major and important contribution to our understanding' of segmental axon patterning. We note the comment on our use of the chick embryo rather than mouse, which stems from earlier embryo grafting experiments that defined this biological system. Relevant here, we have added a new comment in the Discussion (third paragraph) regarding the mouse mutant screen published by Samuel Pfaff and colleagues, and a reference to this work (Bai et al., 2011). Their <italic>Columbus</italic> mutant has an impressive spinal axon phenotype indicative of a loss of somite polarity (P-to-A). This likely arose because the mutant gene, <italic>Presenilin-1</italic>, regulates Notch signalling that is required upstream to generate P-half somite polarity.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Overall the manuscript is well written and clearly organised into a sequence of logical experiments. It is evident that the authors have substantial expertise in the subject area. However, there are a few things that I would like to see addressed.</p><p>1) In terms of figure presentation, I think it would help enormously to have cartoons of the somite arrangements and the axon tracks coupled with the key molecular cues to set the stage for the study. That is, to describe the anatomy in a classical developmental biology/anatomy context. I don't think this is a minor point. eLife is a journal with a wide audience and the paper is written from the viewpoint of a hard-core developmental neuroscientist, which shows deep understanding of the specialist area, but which might make the paper inaccessible to a larger audience. A summary figure to set out the hypothesis in a first figure, coupled with a summary diagram in a final figure pulling together the various strands of the results would be incredibly useful. Both because of the wide range of specialist techniques used in the study and because there is a wider context in which the study could be interpreted- but there is a lot to digest from the text and the point is difficult to grasp in places.</p></disp-quote><p>Regarding the need for a diagram of the developmental anatomy, we entirely agree with the reviewer that this will help readers unfamiliar with this system, and have added the requested summary figure (new Figure 1A) to clarify the anatomical relationships.</p><disp-quote content-type="editor-comment"><p>2) The authors say that ….'co-injection of siRNA…rescued the normal segmented phenotype (Figure 2….)'. But looking at the data in the figure I think it is best to say that the phenotype was rescued partially.</p></disp-quote><p>We take the point that we did not see complete rescue and have stated that the phenotype was rescued 'partially' as suggested (subsection “csPDI mediates spinal nerve patterning in vivo”).</p><disp-quote content-type="editor-comment"><p>3) A major point of the paper is that the authors have identified a growth cone collapse mechanism and they use a collapse assay (collected data are based on morphology) but there are no photographs of the growth cones in any of the figures. It would be useful to have images so the reader can get a feel for what 'collapse' looks like, especially with respect to soluble and contact mediated factors. For example, when the growth cones are challenged with soluble factors or liposomes: how do liposomes interact physically with filopodia in these cultures as compared to soluble factor influences on growth cone morphology (important because, as the authors state, a single filopodial contact can make all the difference)? They report time course data, so they must have time lapse images of growth cones as they collapse from which such measurements were made. These would be useful for the reader.</p></disp-quote><p>Regarding the presentation of images of collapsed growth cones, we have clarified this in the Materials and methods section (subsection “Growth cone collapse assays”). We have made it clear that collapse is defined morphologically as loss/conversion of the entire growth cone structure (i.e. both filopodia and lamellipodia) to a needle-like point, with no more than two filopodia. We have additionally referred to images of collapsed growth cones in a previous publication from our lab (Manns et al., 2012, Figure 1K, L). These show that using phase-contrast optics to visualise growth cones, as we have also done here, compares favourably with phalloidin staining of growth cones. Regarding the reviewer's further comment on liposomes, as a control we use liposomes that have not incorporated any proteins, and routinely we find they do not cause collapse beyond the background levels also seen after addition of phosphate-buffered saline.</p><disp-quote content-type="editor-comment"><p>4) In a similar vein, given the importance of growth cone collapse and the role of the identified molecular mechanism on axon pathfinding I'm wondering why the authors did not include 'classical growth cone turning assay' or 'stripe assay' experiments. I am not necessarily requesting additional experiments, but if the authors have such data they would add to the study.</p></disp-quote><p>Regarding use of the stripe- and turning assays, we did not investigate these for purification purposes; they would have been far more time-consuming and thereby less suitable for the large number of multiple assays required for biochemical purification and characterization.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>This manuscript provides a satisfying answer to a question that has long been elusive. For the most part the data are very robust and well-documented. However, I suggest two types of improvements. First, other molecules, including ones described by the Keynes laboratory, are also implicated in preventing axons from entering the posterior half somite. This should be discussed. I think it would be very helpful to include a model figure that shows how PDI operates, as they describe in the Discussion, and also includes these other molecular mechanisms. Second, a number of figures could be improved.</p></disp-quote><p>– Other candidate repellent molecules have been discussed as requested (Discussion, together with associated new references). We have also added a sentence regarding previous studies indicating a role for NO signalling in synapse elimination during brain development.</p><p>– Also as requested we have added a new figure (Figure 5) to illustrate the proposed operation of csPDI. We do agree that addition of the other candidate molecules is very helpful, and the relevant information is now included in the Discussion as noted above. We would prefer not to add these other candidate molecules to this figure, feeling it would become cluttered with too much information as a result.</p><disp-quote content-type="editor-comment"><p>1) Figure 1: It would be helpful to box the regions blown up in D-F.</p></disp-quote><p>Figure 1D-F: boxes have been added as requested.</p><disp-quote content-type="editor-comment"><p>2) Figure 1—figure supplement 1: It's very difficult to see what's going on in panel C. Asterisks or some other marker would help.</p></disp-quote><p>Figure 1—figure supplement 1C: arrows have been added for greater clarity.</p><disp-quote content-type="editor-comment"><p>3) Figure 2: Is the loss of PDI random in these experiments? It looks like after siRNA it is gone in some somites and still present in others. Is this consistent? If so, how do you know whether it is effective?</p></disp-quote><p>Figure 2 – regarding whether loss of PDI is random. Panel A shows that fluorescein-labelled siRNA was delivered into several consecutive somites after a typical injection experiment. Therefore, in respect of siRNA distribution in a contiguous row of somites, we did not predict randomly-distributed loss of PDI from segment-to-segment. Abnormal outgrowth patterns were seen in consecutive segments, as shown in panels C and D (on the right in each image); these panels also show normal segmented outgrowth in more posterior segments (to the left in each image), presumably where siRNA delivery was diminished compared with the abnormal segments. The legend has been modified accordingly to make this point clearer.</p><p>In the case of a single somite we did not expect the knockdown to affect every cell within it, nor did we see evidence for this. Figure 2—figure supplement 2J and K show a scattered distribution of sclerotome cells expressing PDI (J) and the FLAG M1 epitope (K). In view of the cell-surface-localized nature of the contact-based repulsion mechanism, we would expect such somites to elicit the sprouting defects as described. We find no evidence that P-half-somite cells secrete an axonal repellent (Keynes et al., 1997), so cells that escape the siRNA would not be expected to compensate knocked-down cells in the same somite. We prefer not to lengthen the Discussion with these arguments but will do this if so required.</p><disp-quote content-type="editor-comment"><p>4) Figure 2—figure supplement 2. It would be very helpful to show a blow up with comparisons for panel H.</p></disp-quote><p>Figure 2—figure supplement 2H: the magnification has been increased.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>While reviewers 2 and 3 found that the changes to the figures, especially Figure 1, clarified the experimental outcomes and interpretation, there were three remaining amendments suggested:</p><p>1) In the figure legend for new Figure 1, you refer to '…mixed spinal nerves (yellow)’ but there is no yellow in the figure. Neither the arrow pointing to the nerve nor the nerve itself is yellow, so you may want to amend this.</p></disp-quote><p>We have deleted '(yellow)' from the figure legend as we feel this is redundant since the 'mixed' spinal nerve is described in the legend and identified with an arrow in the figure.</p><disp-quote content-type="editor-comment"><p>2) New Figure 5 is also helpful, but reviewer 3 found the large red arrow at the bottom confusing. Is this meant to indicate retraction? If so, that should be described in the legend.</p></disp-quote><p>Yes, the large red arrow is meant to indicate retraction and this is now clarified in the legend.</p><disp-quote content-type="editor-comment"><p>3) Reviewer 3 wonders why the you chose not to include an image of a collapsed growth cone, as suggested originally by reviewer 2. This would make the article more accessible to readers, without them having to look at additional references.</p></disp-quote><p>We have revised Figure 3—figure supplement 3 by incorporating an additional panel (new panel B) showing spread and collapsed growth cones in the PDI+GSNO experiment. We have also made the necessary accompanying minor changes to the main text and the figure legend to accommodate this amendment.</p></body></sub-article></article>